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ABSTRACT
A general method for the preparation o f a wide variety o f phosphonate 
derivatives, including phosphonamides, thiophospbonamides, thiophosphonates, and 
dithiophosphonates, from reduced phosphorus intermediates has been developed. 
Esters (or thioesters) o f tf-phosphinates are converted to the highly reactive 
phosphonochloridites by non-oxidative activation with dichlorotriphenylphosphorane. 
The phosphonochloridites react readily with alcohols, amines and thiols and after in situ 
oxidation or sulfurization, phosphonate derivatives can be isolated in moderate to very 
good yields (47-85%). This method was used to synthesize a thiophosphonate 
dipeptide, Boc-Val-i/f[P(S)(OBu)0 ]Ala-C>CH3 (15b), two thiophosphonam ide 
dipeptides, Boc-Val-i/4 P(S)(OrBu)NH]Gly-OCH2CH3 (1 6 b) and Fm oc-A ib- 
i/4P(S)(OBn)NH]Gly-OCH2CH3 (20), and two phosphonate dipeptides, Fmoc-Aib- 
i^[P(0)(0Bn)NH]Gly-0CH2CH3 (1 9 )  and Fmoc-Phe-V'tP(S)(OBn)NH]Gly- 
OCH2CH3 (21). Compounds 15b , 16b and 20 represent the first five examples of 
such monothiophosphonopeptide analogues and compounds 19 and 20 the first 
incorporation o f  a highly sterically hindered Aib-phosphonate amino acid into a 
phosphonopeptide. The successful preparation of 15b, 16b, 19,20 and 21 demonstrates 
the compatability of this method with a variety of potentially sensitive functionalities 
and applicability to easy preparation of new classes of peptide mimics.
To test our chemistry on the solid-phase we prepared known and potential 
inhibitors. The phosphonoamidate peptides Z-Aibi//[(POOBn)NH]-Phe-OH (25), 
Z-Aiby/[(PC)0-)NH]-Phe-OH (26) and Z-Gly i//[(POQ-)NH]-Phe-OH (27) synthesized 
could not be isolated or purified due to instability factors, but we could isolate and 
characterize the phosphonate peptide Z-Phe-i//[(POO“)0]Phe-Ala-NH2 (29).
xv
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CHAPTER 1. INTRODUCTION
1.1. Phosphonates and Phosphonopeptides
The synthesis o f biologically active compounds has long captured the interest of 
organic chemists. An increasingly important influence on the design o f biologically 
active compounds is being exerted by mechanistic understanding o f enzymatic 
processes. Suicide inhibitors and transition state analogues are am ong the more 
effective types of enzyme inhibitors to arise from this approach.1"4
Phosphonates and their derivatives are important analogs o f nucleic acids,5 
peptides,6' 19 lipids,20 other biologically important phosphates,21 and as haptens for 
preparation of catalytic antibodies.22 Phosphonopeptides, an im portant class of 
biologically active peptide mimics, have been employed as effective inhibitors of 
metallo-6*15, aspartyl16' 17, and serine18' 19 proteases. Mechanism and structure-based 
phosphonopeptide inhibitor design has provided a number of excellent lead compounds 
having potential pharmaceutical utility (Figure 1.1).
Zinc and aspartic proteases function by similar mechanisms, both catalyze the 
hydrolysis o f the amide bond in an oligopeptide substrate with form ation of a 
tetrahedral intermediate. Both mechanisms involve either basic, acid or Lewis acid 
catalysis first from a carboxylate side chain and second from another functional group 
in the active site (Scheme 1.1). Because of the similarities in mechanism between these 
classes of enzymes, phosphorus-containing peptide analogues, which mimic the 
tetrahedral intermediate, are potent transition-state analogue inhibitors o f  zinc and 
aspartic proteases (Scheme 1.2).
1
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-)
OH
Z-Phe-Val\y[(P02~)0]Phe-0H
competetive inhibitor of 
carboxypeptidase (Zn2+ protease)12
Z-Ala-Ala-Leuvj/[(P02-)0]Phe-0CH 3
competetive inhibitor of 
pencillopepsin (aspartyl protease)16
H I  I 0
h Q P
OCH<
Boc-Ala-Ala-Pro-Val\|/[(P02Ph)0]Ala-Ala-OCH3
Irreversible inhibitor of 
human leukocyte elastase (serine protease)18
"OH
Z-Gly\|/[(P02-)NH]Leu-Ala-OH
Competetive inhibitor of 
thermolysin (Zn2+ protease)13
Figure 1.1. Phosphonopeptide Inhibitors
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Zinc protease mechanism
R’NH R
-G Iu-C 02 "r -'o h
.Zn +
Aspartic protease mechanism
R'NH
—A sp-C 02 H-t)H
A sp-C 02H
R'NH
—Glu-COoH
HO'
tetrahedral intermediate
R'NH
-A s p -C 0 2H
H 0 OH
sp -C 0 2‘
tetrahedral intermediate 
Scheme 1.1. Zinc and Aspartic- Protease Mechanism
Zinc protease inhibition
O X R
G 'u -C (©  /
O— -H -0  s O ---
Glu-C
-H-N-His
X R
O H ~ - q ^ p -  
^  \ /
Zn,2+ 
\
% t 
\  $
Zn.2+ 
\
-H-N-His
Aspartic protease inhibition
Asp
0 =
Asp-C02H^
; V ° v
H
H
+ H
-H ©
0 = <
Asp
©  Asp-C02H%
b v © /
- V ° ' H
Scheme 1.2. Phosphorus-containing Analogs Which Mimic the Tetrahedral
Intermediate
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1.2. Phosphonate and Phosphonopeptide Solution and Solid-Phase Synthesis
Currently, phosphonate esters, phosphonate ester peptide analogs (1, X = O, Y = 
O, Z = O), phosphonamidates and phosphonamide peptide analogs (1, X = NR, Y = O, 
Z = O) are generally formed by first activating a phosphonate monoester to the 
phosphonochloridate with thionyl chloride6' 19 or oxalyl chloride,23' 26 followed by 
coupling o f the activated species with an alcohol or amine in the presence of base 
(Scheme 1.3, Path A ).27
1 9 , a
R - R T  ,
OR"
„ 4 xr3
1 YR2
X = O, NR, S 
Y = O, S 
Z  = 0 ,S
■7"
.Cl
YRJ
\
[ B |
,1 ° .O HR '- P ,
no r 2
Scheme 1.3. Retrosynthetic Analysis of 1
The yields when reacting amines with the intermediate phosphonochloridates or 
benzotriazole esters is, in general, less successful. Moroder and coworkers have recently 
optimized conditions for phosphonamidate formation from phosphonochloridates by 
using oxalyl chloride in presence of catalytic amounts o f  DMF which are then coupled 
in the presence of catalytic AgCN.25 The moderate yields of the desired products in 
solution-based protocols are due to several factors including ( 1) the inherently slow 
nucleophilic attack o f heteroatom  nucleophiles on P(V) centers;28 (2) the use of 
approximately equimolar quantities of nucleophilic and electrophilic components; and
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(3) requirement for purification of the phosphonate or phosphonopeptide product before 
continuing the synthesis.
An alternative approach to phosphonate diesters uses a modified Mitsunobu 
coupling o f a phosphonate monoester with an alcohol (inversion of configuration at the 
alcohol-bearing carbon) as a limiting reagent.29 The modifications are the use o f an 
exogeous base and electron-deficient phosphines. This method suffers from long 
reaction times with sterically hindered alcohols and phosphonates (Scheme 1.4).
— 0 2C— N = N —COg—^
(4-CI-Ph)3P
f l
R -PC
OR'
OMe
(4-CI-Ph)3P O
r - p :
OMe
^>— 0 2C -N —N - C 0 2—  
(4-CI-Ph)3P+
Et3N R - P T OH
OMe
o 2c - n— n - c o 2-
(4-CI-Ph)3P+
R'OH
R'O—P(Ph-CI-4)3 + / ^ - 0 2C ~ N - N - C 0 2—^
Scheme 1.4. Modified Mitsunobu Reaction for Condensation of Phosphonates and
Alcohols
Dithiophosphonate esters have recently become available by addition of alcohol 
nucleophiles to 2-alkyl-2-thio-l,3,2-dithiaphospholanes.30 This method involves the 
reaction of Grignard reagents with 2-chloro-l,3,2-dithiaphospholane and sulfurization
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6of the formed compound with elemental sulfur to produce the phosphonotrithioates. 
These com pounds react with a variety o f alcohols in the presence of 1,8- 
diazabicyclo[5.4.0]undec-7-ene (DBU) to produce phosphonodithioates (Scheme 1.5).
S -^  RMgX j S ^  sulfur
C' - P x J  ----------- ►
S S- Benzene
c o  ©  0  S  ^
HOCH2CH2NMe3 OTs „  «i ^  ^  ©
'p v J --------- -— -^----- 2---------   R -P -O C H 2CH2NMe3
R S DBU
Scheme 1.5. Synthesis of Phosphonodithioic Acid Derivatives
In attempt to improve phosphonopeptide synthesis, several groups have 
incorporated phosphonate amino acids into peptide chains by solid-phase methods. This 
allows for use o f excess reagents to help compensate for the slow kinetics and remove 
the need for purification. A protected-phosphonamide dipeptide has been used in solid- 
phase synthesis o f phosphoamidate peptides.31 While this method was effective for 
incorporation o f a phosphonamide linkage into a peptide, it requires that protected 
phosphonamide dipeptides first be prepared in solution (Scheme 1.6).
1. A^Expansin0
R o  BOP/DIEA R 0
F m o c - N H ^ ^ - N H ^ C O O H ----------------   P iA2-N H ^ F > -N H ^ C O A 1OH
OR' „ D. ... OR'2. Pipendine
3. P-|A2 ,
R= CH3i R'=CH2Ph BOP/DIEA P iA2 = Boc-Phe, R= CH3,
R=CH2Ph, R'=CH3 R-Bn, =Ala
P-|A2 = Ac-Ala, R=CH2Ph, 
R'=CH3 , A1= Val-Val-Ahx
Scheme 1.6. Synthesis of Phosphonamide Dipeptides
To date there is only one reported solid-phase method for formation o f the 
phosphonate linkage on the support, and this chemistry is limited to phosphonate esters
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o n ly 32 (Scheme 1.7). New com binatorial chem istry  for making arrays of 
phosphonopeptides to screen for activity appears promising, except that reliable 
methods for coupling phosphonate amino acids are limited in scope.33 Unfortunately, 
these reactions are highly dependent on steric factors and couplings can take more than 
12 hours to go to completion. Campbell and coworkers synthesized three active 
peptidylphosphonates, thermolysin inhibitors, using a combinatorial library: Z-(R,S)- 
Phe\|/[(P02-)0]Leu-A rg(N H 2) (K; = 64 nM), Z-(R,S)-Phe\|/[(P02-)0]Leu-ffis(NH2) 
(Kj=57) and Z-(R,S)-Phei|f[(P02-)0]Leu-Ala(NH2) (K; = 4 9  nM) (scheme 1.7).34-35
Recently, Lloyd et al. reported the solid-phase synthesis o f a series of 
phosphinic acid containing inhibitors (Z-Phe\jr[(P02H)CH2]Phe-Ai(0H)) (A j = Trp, 
Val, Arg, Thr, Glu, Tyr, lie) that have greater chemical stability and similar inhibition 
o f endothelin covertin enzyme (ECE) when compared to phophoramidon, the most 
potent inhibitor known.36
1.3. Goal of the P resent Research
The overall goal o f this research is to create a new, general, high yielding 
method for the preparation of a wide variety o f phosphonate derivatives, including 
phosphonamides, thiophosphonamides, thiophosphonates, dithiophosphonates and to 
improve the access to phosphono-substituted peptides. This will allow these important 
molecules to be more readily available for biological and medicinal applications and 
additionally, new derivatives with sulfur ligands on the phosphorus can be readily 
prepared. Ultimately, these new chemistries could be applied to array technologies for 
synthesis o f thousands of compounds simultaneously, thus allowing even more rapid 
development o f protease inhibitors and increasing our understanding of what chemical 
requirements exist for strong protein-inhibitor interactions.
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2. HBTU, HOBt, 
DIEA, NMP
3. piperidine
H9N^_-XN-
H
1. HBTU, HOBt, 
DIEA, NMP
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X OMe
__________________ r 3 r
2. (4-CI-Ph)3P 
DIAD/DIEA
3. DBU /  NMP
MeO O p2 H O
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1. Z-CI, DIEA, 
dioxane
2. thiophenol, 
Et3N, dioxane
3. triethylsilane, 
TFA
H O .0  i 2 H 9
Z H N ^ -P -oA ^ n ^ X NH;
p 3 0  P,
Scheme 1.7. Solid-Phase Peptidylphosphonate Synthesis
We report herein a new method to prepare phosphonates whereby P(III) 
compounds (2) are used in the coupling step (Scheme 1.3, Path B). In addition to 
potentially increasing the yield of 1, this approach also allows for easy design and 
preparation of phosphonates with a wide variety o f heteroatoms around the phosphorus 
center (e.g., X = NR, Y = O, Z = S or X = O, Y = S, Z = S), many of which are difficult 
or impossible to prepare by current methodologies.
As nucleophilic displacement is much faster at P(III) than at P(V) centers, we 
hope this new phosphonate synthesis will increase the yield and efficacy of production
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of 1. The basis for this approach was the observation that phosphorochloridites, such as 
(C2HsO)2PC1 and C6H 5OPCI2, react very rapidly at the 3'-OH o f nucleosides in 
pyridine, even at very low temperatures giving relatively good yields. By contrast, the 
reactions o f the analogous chloridates, (RO)2POCl and R0 P(0 )Cl2, require several 
hours at room temperature.28
For oligonucleotide synthesis, the phosphotriester approach [P(V)] has been 
almost entirely supplanted by the phosphoramidite and H-phosphonate methods, both of 
which rely on P(III) chemistry. The phosphoramidite method, which is based in part on 
the earlier work o f Robert Letsinger,28 is currently widely used because it is readily 
adaptable to automated DNA synthesis machines and leads to very high yields of 
relatively pure polynucleotides. These achievements are due primarily to the stability of 
the deoxynucleoside phosphoramidites, the high yields per nucleotide addition, and the 
very short reaction times (less than 1 min). The overall yields, speed o f synthesis, and 
the quality of DNA from the H-phosphonate coupling method has yet to match the 
phosphoramidite methodology.37
The success o f the P(HI) methods for oligonucleotide synthesis37 is in large part 
due to the com m ercial availability o f  mononucleoside derivatives that can be 
manipulated under ambient conditions by the non-expert. In this light, we envisioned 
/f-phosphinate esters 2 as the ideal precursors for a P(m)-based phosphonate synthesis 
because o f their air stability. tf-Phosphinates are tautomeric with phosphonites 
[RP(OR)(OH)], but reside almost exclusively in the P = 0  form. Without a free lone pair 
o f electrons, the tf-phosphinate tautomers are kinetically and thermodynamically much 
more difficult to oxidize than is expected for a 3-coordinate P(IH) compound.
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CHAPTER 2. A SYNTHESIS O F PHOSPHONATE AND 
TH IOPH O SPH O N A TE ESTERS AND AMIDES FR O M  HYDROGEN- 
PHOSPHINATES BY A NOVEL ONE-POT ACTTVATION-COUPLING-
OXIDATION PROCEDURE
2.1. Results and Discussion
To be practical for phosphonate synthesis, //-phosphinates esters 2 must readily 
be converted to an activated species (e.g., RP(OR')(Cl), phosphonochloridites; Scheme
1.3, Path B). Hata and coworkers reported that nucleoside //-phosphonate diesters 
[(RO)2PHO] could be non-oxidatively converted to the phosphorochloridites 
[(RO)2PCl] with dichlorotris(2,4,6-tribromophenoxy)phosphorane.38 We used a crude 
preparation of dichlorotris(2,4,6-tribromophenoxy)phosphorane (31P, -64.9 ppm) 
[con tam inated  w ith  ap p ro x im ate ly  50 mole % o f trich lo ro b is(2 ,4 ,6 - 
tribromophenoxy)phosphorane (31P, -72.1 ppm)] to activate menthyl phenylphosphinate 
(2a)39 in pyridine. The corresponding phosphonochloridite 3a was produced in high 
yield (as shown by 31P-NMR) and then was readily coupled to a variety of alcohols to 
provide phosphonites 4a (XR3 = OCH3, OEt, OiPr, OCH2PI1) which after sulfurization 
gave thiophosphonates l a  in good isolated yields (data not shown) (Scheme 2.1).
r , _ 9 . H  (R)3PCIa R l_ ~ „ c i  HXR3
Yr 2 Pyridine y r 2 Pyridine
2a, R1=Ph, YR2=OMen 3a, R1=Ph, YR2=OMen
2b, R1=Ph, YR2=0/Pr 3b, R1=Ph, YR2=0/Pr
2c, R1=Me, YR2= O S u 3c , R1=Me, YR2=0/Bu
2d, R1=Me, YR2=S© u 3d, R1=Me, YR2=S© u
r 1_ . . . X r3  [O] or [S] r , _ ^ X R 3
Y r 2 Pyridine YR2
forR1 = Ph 1a, R1=Ph, YR2=OMen,
4a, YR2=OMen, XR3=OR XR3=OR, Z=S
4b-4l, see Table 1 1b-1n. see Table 1
for R 1 = Me 1 °*2R =Rh- 5=0 ,
4m-4n, see Table 1 YR2, XR = O/Pr
Scheme 2.1. Synthesis of Compounds la - lo
10
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The successful reaction with this crude preparation o f dichIoro-tris(2,4,6- 
tribromophenoxy)phosphorane suggested that other chlorophosphoranes might be used 
for the same purpose. Commercially available dichlorotriphenylphosphorane (95% 
purity, A ldrich) was used under the same conditions to activate isopropyl 
phenylphosphonite (2b) to produced almost exclusively phosphonochloridite 3b (31P- 
NMR, Fig. 2.1). Subsequent addition of methanol gave the phosphonite 4d, which was 
sulfurized to provide the thiophosphonate Id .
(PhfcPaO
24 5 I
174.0
153.8
85.2
X X X X PPMX X X X
Fig. 2.1. 31P NMR o f Activation-Coupling-Oxidation Procedure
A. Reaction of //-phosphinate 2b (3 ,P = 20.1 ppm) with dichlorotriphenylphosphorane 
(Ph3PCl2) in pyridine to produce phosphonochloridite 3b (3IP = 174.0 ppm; 30 min. 
reaction time). Peak at 24.5 ppm in each spectrum is triphenylphosphine oxide 
((Ph)3P=0).
B. Reaction of phosphonochloridite 3b with methanol to produce phosphonite 4d (31P = 
153.8 ppm; 30 min. reaction time).
C. Reaction of phosphonite 4d with Ss to produce thiophosphonate Id  (31P = 85.2 ppm; 
30 min. reaction time).
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Table 2.1 describes the preparative experiments performed with tf-phosphinates
2b-d. All o f the experiments used equimolar 2 and nucleophile (R3XH), except when
amines were used as the nucleophiles.
Table 2.1. Preparation of Phosphonate and Phosphonamides from
£f-Phosphinates
Entry R1 YR2 XR3 Z Yield of 1 31P (4)a 31P ( l ) fc
b Ph OiPr OBn 0 71% 153.2f 15.9
c Ph OiPr NEt2 0 61%c>* 125.9 8 18.9
d Ph OiPr OMe s 85% 153.8 85.2
e Ph OiPr OEt s 70% 152.3 83.2
f Ph OiPr OiPr s 71% 151.6 81.4
g Ph OiPr OBn s 66% 153.2f 83.8
h Ph OiPr OrBu s 70% 141.4 74.5
i Ph OiPr NHBn s 75%c 111.2 72.3
j Ph OiPr NEt2 s 75%c,e 125.95 74.6
k Ph OiPr NHrBu s 75%c 102.2 68.2
I Ph OiPr SPh s 83% 144.8 88.7
m c h 3 OrBu NHrBu s 61%4 96.4 69.4
n c h 3 SrBu o ch 3 s 47% 136.0 98.8
a 8 of crude reaction mixture (pyridine). ^ 8 of purified 1 in CDCI3 . c For lc , li-k, 
lm , 4 equiv (10.4 mmol) o f amine nucleophile were added. ^ 3  equiv. (7.8 mmol) of 
amine nucleophile were added. e Pressure alumina chromatography was used for 
purification. /4 b  = 4g, PhP(OBn)(OiPr). 8 4c = 4j, PhP(OiPr)(NEt2).
Table 2.1 summarizes our results with activation o f 2b-d (see section 2.2.2 for 
methods o f preparation) by  PI13P C I2 and reaction o f the subsequent 
phosphonochloridites with alcohols, amines or thiols, followed by sulfurization or 
oxidation to provide thiophosphonates, thiophosphonamides and dithiophosphonates or 
phosphonates and phosphonamides respectively. The alcohols used were methanol, 
ethanol, isopropanol, benzyl alcohol and r-butyl alcohol and the thiol used was 
thiophenol. The amines used were diethyl amine, benzyl amine and r-butyl amine. The 
isolated yields for all the various phosphonate derivatives were excellent to moderate. 
All products were obtained in greater than 90% purity after chromatography. Entry Id 
(85%) shows the highest and entry In (47%) the lowest yield obtained. Particularly 
noteworthy are the good yields for compounds lh (71%), lk  (75%) (Figure 2.2), and
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lm  (61%), all which incorporate a very hindered r-Bu group in the alcohol or amine 
nucleophile. Such compounds are difficult to prepare by P(V) approaches because of 
the sensitivity o f these reactions to steric factors. For reactions with 2b, the major 
contam inant (3-10% , GC) was the diisopropyl phosphonate lo  or diisopropyl 
thiophosphonate If. These products are formed by oxidation or sulfurization of 
diisopropyl phenylphosphonite (4f), which is apparently formed by disproportionation 
of 2b and phosphonochloridite 3b (see 3IP NMR Figure 2.1).
For the reactions of amines, excess of the amine (4 equiv) was required to obtain 
good yields of phosphonamides. An early experiment employing phosphonochloridite 
3b (R 1 = Ph, YR2 = OiPr) and an equivalent amount o f benzylamine produced a 
mixture o f three compounds in a —1:1:1.3 ratio (3IP: 124.0, 123.9 and 111.2 ppm 
respectively). After sulfurization only two main signals were present in the 31P 
spectrum (ratio 2:1.3, 79.2 and 72.3 ppm, respectively); the products were separated by 
flash chromatography and the faster running material was crystallized from hexane. The 
*H NM R lacked an exchangeable resonance an tic ipated  for the NH of 
thiophosphonamide l i  and the integration showed half the expected number of benzylic 
protons. X-ray analysis confirmed the structure as the thiophosphonimide 5 (Figure 
2.3). The requirement for excess amine relates mainly to the basicity of benzylamine 
(pKb = 4.70) relative to the solvent pyridine (pKb  = 8.77). W ith only 1 equiv of 
benzylamine, 50% reaction to form phosphonamidite 4i generates one-half equiv. of 
HC1 that is then competetively scavenged by the remaining benzylamine (0.5 equiv.) 
and pyridine (solvent, -24  equiv.) (Scheme 2.2). Even though the pyridine is present in 
large excess, the greater basicity o f benzylamine means that it will be essentially 
completely protonated under these conditions. The intermediate 4i is apparently still 
nucleophilic enough on nitrogen to react with remaining 3b to form bisphosphinoamine 
6 (123.9 ppm), which upon sulfurization produces 5. The above hypothesis was 
confirmed in NMR-scale experiments; benzylamine added to a solution of 3b in
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pyridine and excess Et3N (pKb = 3.24) gave almost exclusive formation of the desired 
4i without any 6.
Interestingly, the crystalline thiophosphonimide was isolated in only 40% yield 
in the racemic form (5-rac). The prisms o f 5-rac crystallized in space group P2i/n and 
had approximate C2-symmetry in the solid-state. A high selectivity for the racemic 
isomer over the meso-isomer is not expected. Apparently, the 5-rac and 5-meso have 
identical 31P shifts (79.2 ppm). The presence of two 31P resonances for the inferred 
precursors to 5, intermediate 6 (124.0 and 123.9 ppm in a 1:1 ratio), supports the idea 
that 5 is produced as a mixture of meso and racemic forms.
Ph~R
•/C l
\
O P r
3b
H2NBn
Pyridine
1 /2B n N H ?C P  +
.NHBn
1/2Ph-Px
O Pr 
4i, 111.2
S
n
■ N '^ - P h  
PrO Bn O/Pr
P h ^ p '
+ 1 /2 P h -F fC ‘ 
O Pr
3b
-HCI
Ph— R NHBn
NO Pr 
1i, 72.3
P h ^ P 'N ' P^ P h  
PrO  Bn O Pr
6 , 124.0, 123.95, 79.2
Scheme 2.2. Form ation  of Compounds 5 and  l i
2.1.1. Stereoselective Coupling Studies
To determine whether this method might be useful for stereoselective coupling 
of phosphorus compounds, pure Sp-menthyl phenylphosphinate 2a was reacted under 
the standard conditions as used for the preparation of la-lh. Activation gave a single
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peak in the 31P-NMR at 177.4 ppm for the phosphonochloridite 3a; addition of ethanol 
produced two resonances for the diastereomeric phosphonites 4a (R = Et) in an 8:5 ratio 
(154.6 and 153.2 ppm respectively). Sulfurization of the phosphonites provided an 8:5 
mixture o f two thiophosphonates l a  (R = Et; 31P, 83.4 and 82.5 ppm respectively; 
absolute stereochemistry unknown). As it is known that heteroatom nucleophiles react 
with phosphorus chlorides with inversion (S n2(P)),29 most likely the activation of the 
/f-phosphinate is partially racemizing the P-center. The apparent single isomer of 3 a 
formed is probably a mixture of diastereomeric phosphonochloridites with identical 5 
(Scheme 2.3).
CIO
C13
C ll
Cl 2
Fig 2.2. O R TE P Drawing of lk
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Fig 2.3. ORTEP Drawing of 5
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Ph3PCI2
ovridine P h r f ^ X  + X " - f > hpyndine MenthO MenthO
3a 177.4
2a 21.8
-  HCI EtOH
D  D  ^ 8  * * * *
PhrT-OEt + OEt'-f-  ---------------  Phrf-oEt + Et0  ^ Ph
MenthO MenthO MenthO MenthO
1a, 83.4, 82.5 4a, 154.6, 153.2
Scheme 2.3 Stereoselective Coupling Studies
2.1.2. Synthesis of iZ-Phosphinates and  oc-Amino-Alkyl-/7-Phosphinates
Menthyl phenylphosphinate (2a), first prepared by Letsinger and coworkers,39 
was obtained by the reaction o f (+)-menthol with PI1PCI2 followed by hydrolysis. The 
mixture of menthyl phenylphosphinate diasteromers (4:3) was separated by HPLC on a 
Chiralcel OD column in hexane:isopropanol (85:15). Isopropyl phenylphosphinate (2b), 
r-butyl methylphosphinate (2c) and r-butyl methylphosphonothioite (2d) were prepared 
by an adaptation of the method of Emmick and Letsinger for the preparation of menthyl 
phenylphosphinate (Scheme 2.4).
The a-amino-alkyl-if-phosphinates 7 c and 8c were prepared according to 
Haemers et. al.40 A solution of the corresponding protected imine in THF or CHCI3 was 
added to the in situ generated bis(trimethylsilyl) phosphonite (Scheme 2.5).
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1. HYR2, pyridine 
in toluene or THF
. - C l  2 H 2 °  , V h
R 1—Rf -----------------------------------   R '-F T
Cl YR2
R1=Ph, Me 2a, R1=Ph, YR2=OMen
2b, R1=Ph, YR2=0/P r 
2c, R1=Me, YR2= 0 © u  
2d, R1=Me, YR2=S© u
Scheme 2.4. Synthesis of /7-Phosphinates
CPh,
(Me3SiO)2PH
THF(CHCI3), rt, 12 h
7b, R = CH(CH3)2 
8b, R = H
Me3Six CPh3 
N
l_j ^O SiM e3
1. MeOH/HCI 1N 
15 min reflux
2. anhydrous EtOH 
propylene oxide
R
NH2
a I o
H OH
7c, R = CH(CH3)2 
8c, R = H
Scheme 2.5. Synthesis of 1-Aminoalkylphosphinic Acids 7c and 8c
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The inline 9a, used in the synthesis of 10c, was obtained by reaction of acetone 
with benzhydry 1 amine under strict neutral conditions using Bu2SnC h (dibutyltin 
dichloride) as a catalyst. This method is used for the synthesis o f hindered imines.42 
Compound 9c was prepared by mixing methylethylidenebenzhydrylamine 9a with 
hypophosphorus acid (100%). Phenylalanine analog 10c was synthesized with the 
typical procedure41, refluxing phenylacetaldehyde with benzhydrylammonium 
hypophosphite 10a followed by deprotection with 50% HBr (Scheme 2.6).
h 3c  c h 3
C R i v / R 2 ^
H3p 0 * * H ^ p * 0N x t  N
I \  H OH
CH(Ph)2 \
ga 9c  Ri, R2 = CH3
10c R-,= CH2(Ph), R2=H
PhH2C H ©  ©
C + Ph2CHNH3 H3POV 
II 
O
10a
Scheme 2.6. Synthesis o f l-Am inoalkylphosphinic Acids 9c and 10c
2.1.3. Synthesis of Protected a-A m ino-A lkyI-i/-Phosphinate Esters
Compound 7d was prepared according to Bartlett and Sampson's procedure.18 A 
solution o f l-amino-2-isopropylphosphinic acid 7c, 2-[[(r-butoxycarbonyl)oxy]amino]- 
2-phenylacetonitrile (Boc-ON ® ) and Et3N (triethylamine) in DM F were heated 
together at 70 °C. Preparation o f 8 d -1 0 d  was accomplished using a procedure 
developed by Dumy et a l 43 A solution of Fmoc-Cl in dioxane was mixed with a 
solution containing the corresponding a-amino-alkyl-//-phosphinates 8c-10c in water 
(pH=9-9.5) at 4 °C (Scheme 2.7).
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The esters o f the Boc and Fmoc protected a-amino-alkyl-tf-phosphinates 7-13 
were prepared according to Karanewsky and Badia.44 To a solution of 7d-10d in THF 
or CH2Cl2 the following reagents were added in this order: ( 1) the alcohol (r-butyl, 
benzyl or allyl alcohol); (2) 4-dimethylaminopyridine (DM AP) and (3) N,N'- 
dicyclohexylcarbodiimide (DCC). When changing the order of addition undesired 
products are obtained (Scheme 2.7).
R 1V / R2 
H2N ^ p f °  
H OH
Boc-ON, NEt3
in DMF or 
----------------------
Fmoc-CI in 
dioxane
P ^ N
/ \
H OH
7c R-|= CH(CH3)2, R2 = H 
8c R1= H, R2=H 
9c R-j= CH3, R2=CH3 
10c R1= CH2(Ph), R2=H
7d P1= Boc, R1= CH(CH3)2, R2 = H 
8d P-|= Fmoc, Ri= H, R2=H 
9d P-|= Fmoc, R-,= CH3, R2=CH3 
10d P 1= Fmoc, R1= CH2(Ph), R2=H
DCC, DMAP 
P2OH in 
THF/CH2CI2
R1w R 2
P ^ N ^ p ^ 0  
H NOP2
7 P1= Boc, P2=Su, R1= CH(CH3)2, R2 = H
8 P-,= Fmoc, P2=Bn, R-|= H, R2=H
9 P1= Fmoc, P2=Bn, R-|= CH3, R2=CH3
10 P)= Fmoc, P2=Bn, R-,= CH2(Ph), R2=H
11 P-|= Fmoc, P2=allyl, R-,= H, R2=H
12 P ^  Fmoc, P2=allyl, R-,= CH3, R2=CH3
13 P1= Fmoc, P2=allyl, R1= CH2(Ph), R2=H
Scheme 2.7. Synthesis of Protected a-Am ino-AIkvI-/f-Phosphinate Esters 
2.1.4. Synthesis o f M odel Phosphate and  Phosphonam idate Dipeptides in Solution
The relevance o f this method for the preparation o f biologically important 
molecules and its compatability with sensitive functionality was demonstrated by the
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synthesis of five phosphonopeptides (Scheme 2.8 and Scheme 2.9). Under the standard 
conditions (see section 2.2.2 for methods and preparations), Na -B o c-p ro tec ted  
phosphinate amino acid ester 7 was activated with dichlorotriphenylphosphorane in 
pyridine to produce phosphonochloridite 14 (31P, 173.1 ppm). Reaction o f  14 with 
methyl (S)-lactate or glycine ethyl ester (in the presence o f 3.5 equiv. o f  E t3N ), 
followed by sulfurization, produced the novel thiophosphonate and thiophosphonamide 
dipeptides, 15b (31P, 85.4, 85.9 ppm) and 16b (31P, 71.0, 72.0 ppm) in 30% and 40% 
yields, respectively, after column chromatographic purification. This same reaction 
sequence using dichloromethane in place of pyridine as solvent (with Et3N  added to 
scavenge HC1) gave similar results for the production of 15b and 16b (Scheme 2.8).
Scheme 2.8. Synthesis o f Boc-Protected Phosphonodipeptides in Solution
Fmoc-protected phosphonodipeptides (Scheme 2.9) were also prepared under 
the standard conditons (see section 2.2.2 for methods of preparation), A^-Fm oc- 
protected phosphinate amino acid esters 9 and 10 were activated with PI13PC I2 in 
dichloromethane to produce phosphonochloridites 17 (31P. 173.7 ppm) and 18
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Pyridine BocNH p; 
OfBu orCH2CI2/Et3N . . .
7
>L / /  1
BocNH P -N  n
_  1 H Jl
BocNH P - 0  
ffiuO
2 2
(31P, 178.9 ppm), respectively. Reaction of 17 and 18 with glycine ethyl ester (in the 
presence of 3.5 equiv. o f Et3N), followed by sulfurization and/or oxidation, produced 
the phosphonamides and thiophosphonamide dipeptides, 19 (31P, 29.0 ppm), 20 (31P, 
92.0 ppm) and 21 (31P, 28.0,29.0 ppm) in 50%, 40% and 20% yields, respectively.
OX V 2 r . V
f j ' r t  Ph3PC'2 ► F m o c N l A
H OBn CH2Cl2/Et3N
^ Cl 
OBn
9 R1(R2 = CH3 31 P= 37.7 ppm 17 R1,R 2 =C H 3 31 P= 179.7 ppm
10 R ^ C H ^ P h ), 31P= 32.5, 33.3 ppm 18 R ^ C H ^ P h ), 31P= 178.9 ppm 
R2=H r 2=h
©  ©  * o p t
1. Cl H3N ^ Y OEt 
Et3N O
2. anh. t-BuOOH 
or S8
FmocNH
R1 R2 z  
A y /
BnO
19 Z=0, R1t R2 = CH3 31 P= 28.2 ppm
20 Z=S, R1t R2 = CH3 31 P= 92.7 ppm
21 Z=0, R1= CH2(Ph), 31P= 28.0, 29.3 ppm
R2=H
Scheme 2.9. Synthesis of Fm oc-Protected Phosphonodipeptides in Solution
In general, the isolated peptides prepared in solution were obtained in moderate 
to low yields (20%-50%) when using pyridine o r CH2CI2 as solvent. An important 
factor in solvent selection is the solubility o f dichlorotriphenylphosphorane in that 
solvent. DMF, THF and CH3CN were tried with negative results due to solubility or
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side reaction problems. Trie thy lamine or pyridine were used as a base but other bases 
may be used for example diisopropylethylamine or N-methy lmorpholine.
We found no difficulty handling PI13PCI2 as long as it was stored and weighed 
in a dry box free o f water and alcohols and its solutions prepared in anhydrous pyridine 
or CH2CI2. However, a more convenient method could be to generate it in situ. In situ 
preparations were performed by reacting either thionyl chloride or oxalyl chloride with 
triphenylphosphine. Although Ph3PC l2 was obtained in both cases, generation of the 
phosphonochloridite was achieved when using thionyl chloride but not in the case of 
oxalyl chloride. After reacting the generated phosphorane with an //-phosphinate 
compound, the corresponding phosphonochloridite (31P= 174.4 ppm) was obtained with 
other phosphorus compound impurities ( 85.8 ppm, 75.1 ppm, 74.8 ppm, 9.3 ppm, 9.0 
ppm and -0.8 ppm) in a 3:6:1:1:4:4:2 ratio determined by 31P NMR. Palumbo et. al.45 
published the synthesis of halohydrins from epoxides using polymeric phosphine- 
halogen complexes. Using this methodology, our procedure could be modified by 
replacing the phosphorane with a polymer-supported triarylphosphine-halogen 
(polystyryldiphenylphosphine-halogen) complex. This would give a polymer-supported 
triarylphosphine oxide, at the end o f  the reaction, which could be simply filtered off 
without any unnecessary chromatography separation. Inconveniences using this method 
include the handling of chlorine gas and the cost o f the polym er-supported 
triarylphosphine. PI13PCI2 by comparison is inexpensive and is not difficult to handle.
Elemental sulfur provides good sulfurization of the intermediate phosphonite or 
phosphonamidites however, Beaucage reagent46 and 3-ethoxy-l,2,4-dithiazoline-5-one 
[EDITH]47 effective for sulfurization of phosphite triesters in oligonucleotide synthesis, 
could be investigated in this model system. Tetraethylthiuram disulfide (TETD)48 was 
used as a sulfurizing agent with a model phosphonate compound. After a 1 h reaction 
time the desired compound (90.4 ppm) was obtained with a phosphorus compound
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impurity (37.9 ppm) in a 1:1 ratio determined by 31P NMR. Sulfurization with this 
reagent was succesful.
f-Butylhydroperoxide is effective in the phosphonite or phosphonamidate 
oxidation step but other mild organic oxidants, such as m-chloroperbenzoic acid or 
other peracids, or inorganic reagents would probably be useful. I2/H2O was used as an 
oxidizing agent with a model phosphonate compound. This gave the desired compound 
(15.8 ppm) in addition to two other unknown phosphorus compounds containing 
impurities (12.1 ppm and 11.3 ppm) in a 1:3:13 ratio after 1 h reaction time.
In summary, we have demonstrated that phosphonates, phosphonamides, 
thiophosphonates, and the previously unaccessible thiophosphonam ides and 
dithiophosphonates can all be readily prepared from /f-phosphinates using a one-pot 
activation-coupling-oxidation protocol. The key step in this process is the use o f 
Ph3PCl2 as activation reagent to generate the highly reactive phosphonochloridites (i.e, 
3, 8 ,1 7  and 18). This method was used to synthesize a thiophosphonate dipeptide, Boc- 
Val-i//[P(S)(0 rBu)0 ]Ala-0 CH 3 (15b), two thiophosphonamide dipeptides, Boc-Val- 
VA[P(S)(OrBu)NH]Gly-OCH2CH3 (16b) and Fm oc-A ib-y/-[P(S)(O B n)N H ]G ly- 
OCH2CH3 (20), and two phosphonate dipeptides, Fmoc-Aib-i//[P(0)(OBn)NH]Gly- 
OCH2CH3 (19) and Fmoc-Phe-i/4]P(S)(OBn)NH]Gly-OCH2CH3 (21). Compounds 
15b, 16b and 20 represent the first five examples of such monothiophosphonopeptide 
analogues and compounds 19 and 20 the first incorporation of a highly sterically 
hindered Aib-phosphonate amino acid into a phosphonopeptide. The successful 
preparation o f 15b, 16b, 19, 20 and 21 demonstrates the compatability of this method 
w ith a variety o f potentially sensitive functionalities and applicability to easy 
preparation of new classes o f peptide mimics.
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2.2. Experimental Material
2.2.1. Technical Information
All reactions were performed in dry glassware under an atmosphere o f nitrogen. 
Pyridine and toluene were dried by refluxing over CaH2 and then distilling directly onto 
dry molecular sieves (3A). THF was refluxed over Na-benzophenone and distilled just 
prior to use. Benzylamine, diethylamine, f-butylthiol, and r-butanol were dried by 
stirring with molecular sieves and then distilled directly onto dry molecular sieves (3A). 
Anhydrous methanol, ethanol, and isopropanol were purchased from Aldrich. 
Dichlorotriphenylphosphorane was stored and proportioned in a strictly anhydrous 
environment (dry box). NM R spectra were obtained on either a Bruker AC-200 ( 1H) or 
AC-250 ( !H, 31P) spectrometer and were referenced either to internal TMS ( ’H) or 
external H3PO4 (31P). Gas chromatography was performed on a capillary column (HP 17 
Crosslinked, 10m x 0.53 mm, 2.0 pm  film thickness) with the following temperature 
programming: Tjnjt 40 °C for 2 min then 35 °C/min up to Tfinal 270 °C. Elemental 
analysis were performed by MHW Laboratories (Phoenix, AZ).
2.2.2. General Procedure
At room temperature, a solution of dichlorotriphenylphosphorane (95% purity, 
Aldrich, 1.36 g, 3.9 mmol) in pyridine (15 ml) was added dropwise to a solution of the 
tf-phosphinate (2) (2.6 mmol) in pyridine (5 ml). After 30 min, the nucleophile (R3XH) 
(2.6 mmol for alcohols and thiols, 7.8 or 10.4 mmol for amines) was added dropwise 
with stirring and after an additional 30 min sulfur (83 mg, 2.6 mmol) or anhydrous t- 
butyl peroxide (3 M in toluene, 3.5 mL, 10.4 mmol) was added. The reaction mixture 
was stirred for 1 hour. Then the pyridine was evaporated and the residue was triturated 
with hexane (3 x 10 mL). The hexane phase was washed 3 times with saturated aqueous 
N aH C C >3 and dried with N a2SC>4. The compounds were purified using flash 
chromatography on silica gel except where noted and were identified by 31P, !H NMR 
and GC/MS.
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2.2.3. Synthesis and Characterization of //-Phosphinates 
O-Menthyl-P-pheny 1-phosphonite (2a).39
M enthy l pheny lphosph inate  was prepared  from  (-)-m entho l and 
dichlorophenylphosphine according to the method of Emmick and Letsinger.39 To a 
solution containing phenylphosphorous dichloride (25 mL, 0.185 mol) and 100 mL of 
toluene was added dropwise with stirring at room temperature a solution containing (-) 
menthol (28.8 g, 0.185 mol), pyridine (14.9 mL, 0.185 mol) , and 100 mL of toluene. 
Stirring was continued for 2 hours; the pyridine hydrochloride was removed by filtration 
and w ater (200 mL, 11.1 mol) was added slowly with good mixing to the toluene 
solution. The layers were separated and the organic phase was washed with aqueous 
sodium bicarbonate solution, dried with Na2SC>4 and concentrated under reduced 
pressure. The crude product (colorless oil) was purified by distillation (bp 165 °C, 0.1 
mm Hg) and separated into the two pure diastereomers on a Chiracel OD HPLC column 
using hexane-iPrOH (85:15) as the eluent and a flow rate of 3 mL/min. Retention times 
are 23 min (Diast. 2) and 29.5 min (Diast. 1). Yield: 26 g (50%). Diast. 1: /?/7-menthyl 
phenylphosphinate *H NMR (200 MHz, CDCI3) 8 0.92 (m, 9H), 1.20 (m, 2H), 1.46 
(m, 2H), 1.69 (m, 3H), 2.23 (m, 2H), 4.29 (m, 1H), 7.66 (d, JPh=553 Hz , 1H, P-H), 
7.53 (m, 3H, Ph), 7.78 (m, 2H, Ph); 31P NMR (101 MHz, CDCI3) 5 25.3. Diast. 2: 
Sp-menthyl phenylphosphinate !H NMR (200 MHz, CDCI3) 8 0.68 (d, 3H), 0.94 (m, 
6H), 1.33 (m, 4H), 1.68 (m, 3H), 2.06 (m, 1H), 2.28 (m, 1H), 4.25 (m, 1H), 7.68 (d, 
JPH=556 Hz, 1H, P-H), 7.48 (m, 3H, Ph), 7.78 (m, 2H, Ph); 31P NMR (101 MHz, 
CDCI3) 8 21.9.
0-Isopropyl-P-phenyl-phosphonite (2b).49
Isopropyl phenylphosphinate was prepared by adaptation of the method of 
Emmick and Letsinger for the preparation of menthyl phenylphosphinate39: With cooling 
in a dry-ice/isopropanol bath (-70 °C), a solution of isopropanol (14.2 mL, 0.185 mol) 
and pyridine (14.9 mL, 0.185 mol) in dry toluene (100 mL) was added dropwise to a
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
solution of dichlorophenylphosphine (25 mL, 0.185 mol) in dry toluene (100 mL). The 
reaction mixture was allowed to warm to room temperature over 2 hours, at which time 
the pyridinium hydrochloride was removed by filtration. Subsequently, water (200 mL,
11.1 mol) was added slowly with vigorous mixing to the toluene filtrate. The layers were 
separated and the organic phase was washed with saturated aqueous NaHCC>3 solution, 
dried over Na2SC>4 and concentrated under reduced pressure. The pungent crude product 
(colorless oil) was purified by distillation (bp 135 °C, 3.5 mm Hg). Yield: 35.6 g, 95%. 
!H NMR (250 MHz, CDCI3) 5 1.34 (d, J=6.4 Hz, 3H, CH3), 1.42 (d, J=6.0 Hz, 3H, 
CH 3), 4.73 (m, 1H, CH), 7.62 (d, JPh=559 Hz , 1H, P-H), 7.53 (m, 3H, Ph), 7.78 
(m, 2H, Ph); 31p NMR (101 MHz, CDCI3) 5 20.1. 
0 > f 'B u ty I-P -m e th y l-p h o sp h o n ite  (2c).
A solution of f-butanol (0.74 g, 10 mmol) and pyridine (0.79 g, 10 mmol) in 20 
ml THF was added at -70 °C to a solution of methyldichlorophosphine (0.89 mL, 10 
mmol). After wanning to room temperature, the suspension was filtrated and to the 
filtrate was added 25 ml of saturated sodium bicarbonate in water. Extraction with 
dichloromethane and drying with sodium sulfate gave the crude product which was 
purified by distillation (70 °C, 8 mm Hg); significant decomposition occuned upon 
distillation. Yield: 0.31 g (23 % ): lK  NMR (250 MHz, CDC13) 5 1.49 (d, 3H), 1.52 
(s, 9H), 7.38 (d, Jph=533 Hz); 3Ip NMR (101 MHz, CDCI3) 5 23.1. 
5 -/-B u ty I-P -m e th y l-p h o sp h o n o th lo ite  (2d).
A solution of f-butylthiol (1.09 ml, 10 mmol) and pyridine (0.79 g, 10 mmol) in 
20 ml THF was added dropwise to a solution of methyldichlorophosphine (0.89 ml, 10 
mmol) at -70 °C. After warming to room temperature, the suspension was filtrated and to 
the cooled filtrate (0 °C) was added 1 ml saturated aqueous NaHCC>3. After stirring for 1 
minute sodium sulfate was added and the filtered solution was evaporated to give a 
mixture of 2 products, 62% of the crude product. Attempted purification of the product 
by extraction or distillation led to hydrolysis and decomposition respectively. Therefore
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the crude product, which by 31P contained 75% of 2d and 25% of methylphosphinate, 
was used in the standard procedure. NMR (250 MHz, CDCI3) 5 1.62 (s, 9H), 1.78 
(dd, JPH=13.4 Hz, Jhh=3.4 Hz, 1H), 8.20 (dq, JPH=519 Hz, JHH=3-4 Hz, 1H); 31P 
(101 MHz, CDCI3) 8 23.6.
2.2.4. Synthesis and Characterization of Phosphonates and 
Thiophosphonate Esters and Amides
0-Benzyl-0>isopropyI-P-phenyl-phospbonate (lb).
Purified by flash chromatography eluting with hexane: EtOAc (1:1). Yield 71%:
lH NMR (250 M Hz, CDCI3) 8 1.26 (d, J=6.5 Hz, 3H, C H C H 3), 1.35 (d, J=6.3 Hz,
3H, C H C H 3), 4.73 (m, 1H, C H (C H 3)2), 5.06 (m, 2H, C H 2Ph), 7.32 (m, 5H, Ph),
7.49 (m, 3H, Ph), 7.82 (m, 2H, Ph); 31P NMR (110 MHz, CDC13) 8 15.9; MS (El) m/e
290 (11), 248 (42), 167 (47), 142 (100), 107 (42), 91 (97), 79 (11), 78 (29), 65 (28),
51 (13); HRMS (El) m/e calc'd for C i6H i90 3P: 290.1072 ; found: 290.1086. GC tR
14.1 min, purity 90.7%, impurities: lo 8.2%.
jV,iV-Diethyl-0-isopropyI-P-phenyl-phosphonamidate (lc ) .
Purified by pressure alumina chromatography eluting with hexane-EtOAc (5:2).
Yield 61%: *H NMR (250 MHz, CDCI3) 8 1.04 (t, J=7.1 Hz, 6H, 2 CH2C H 3), 1.36
(d, J=5.8 Hz, 6H, C H (C H 3)2), 3.1 (m, 4H, 2 C H 2CH 3), 4.72 (m, 1H, C H (C H 3)2),
7.42 (m, 3H, Ph), 7.74 (m, 2H, Ph); 31P NMR (250 MHz, CDCI3) 8 18.9; MS (El) m/e
240 (15), 198 (80), 141 (17), 77 (33), 72 (80), 58 (100); HRMS (El) m/e calc'd for
C 13H22NO2P: 255.1388; found: 255.1390. GC: tR 11.08 min; purity 94.6%; impurity:
lo , 5.0%.
0*IsopropyI-0>methyl-P'phenyI-phosphonothioate (Id).
Purified by flash chromatography eluting with hexane-EtOAc (10:1). Yield 85%: 
1H NMR (250 MHz, CDCI3) 8 1.23 (d, J=6.0 Hz, 3H, C H C H 3), 1.38 (d, J=6.0 Hz, 
3H, C H CH 3), 3.70 (d, J= 11.8 Hz, 3H, OCH3), 4.88 (m, 1H, C H (C H 3)2), 7.47 (m, 
3H, Ph), 7.9 (m, 2H, Ph); 31P NMR (101 MHz, CDCI3) 8 85.46; MS (El) m/e 230 (81), 
189 (92), 188 (66), 172 (34), 171 (41), 158 (50), 157 (35). 155 (77), 139 (57), 125
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(100), 110 (78), 109 (51), 91 (21), 79 (25), 77 (77), 65 (17), 63 (25), 51 (36); HRMS 
(El) m/e calc'd for C 10H 15O 2PS: 230.0530; found: 230.0538. GC tR 8.37 min, 
purity: 93.8%, impurities: (MeO)2P(S)(Ph), 3.8%, If , 1.8%. 
O -E th y l-O -iso p ro p y l-P -p h e n y l-p h o sp h o iio th io a te  ( le ).50
Purified by flash chromatography eluting with hexane-EtOAc (10 :1). Yield: 
70%. !H NMR (250 MHz, CDC13) 8 1.22 (d, 6.4H, 3H, CHCH3), 1.31 (d, J=6.9 Hz, 
3H, CH2C H 3), 1.37 (d, J=6.2 Hz, 3H, C H C H 3), 4.1 (m, 2H, C H 2C H 3), 4.87 (m, 
1H, C H (C H 3)2), 7.47 (m, 3H, Ph), 7.9 (m, 2H, Ph); 31P NMR (101 MHz, CDCI3) 8
83.2. MS (El) m/e 244 (44), 230 (13), 203 (35), 202 (18), 186 (21), 175 (21), 174 
(17), 169 (25), 158 (39), 157 (35), 153 (22), 141 (100), 125 (51), 110 (26), 109 (34), 
78 (18), 77 (60), 65 (18), 63 (20), 51 (25); HRMS (El) m/e calc’d for C n H i70 2PS: 
244.0687 ; found: 244.0689. GC: tR=10.2 min; purity 99.6%. 
O ,0 -D iiso p ro p y l-P -p h e n y l-p h o sp h o n o th io a te  ( I f )-5 1
Purified by flash chromatography eluting with hexane-EtOAc (10:1). Yield: 71 %. 
NMR (250 MHz, CDCI3) 8 1.21 (d, J=6.4 Hz, 6H, 2 CHCH3), 1.36 (d, J=6.2 Hz, 
6H, 2 C H C H 3), 4.85 (m, 2H, 2 C H (C H 3)2), 7.46 (m, 3H, Ph), 7.91 (m, 2H, Ph); 
31NMR (101 MHz, CDCI3) 8 81.4. MS (El) m/e 258 (40), 217 (11), 200 (10), 183 (27), 
175 (100), 174 (43), 158 (52), 157 (47), 141 (64), 125 (36), 110 (71), 109 (34), 78
(20), 77 (60), 65 (16), 63 (21), 51 (22); HRMS (El) m/e calc'd for C 12H 19O 2PS: 
258.0843; found: 258.0840. GC: tR=10.1 min, purity 100%. 
O -B en zy l-C M so p ro p y l-P -p h en y l-p h o sp h o n o th io a te  ( lg ) .
Purified by flash chromatography eluting with hexane-EtOAc (10:1). Yield: 66%. 
!H NMR (250 MHz, CDCI3) 8 1.24 (d, J=6.3 Hz, 3H, CHCH3), 1.32 (d, J=6.0 Hz, 
3H, C H CH 3), 4.89 (m, 1H, CH (CH 3)2), 5.08 (m, 2H, C H 2Ph), 7.42 (m, 8H, Ph and 
CH 2Ph), 7.91 (m, 2H, Ph); 31P NMR (101 MHz, CDCI3) 8 83.8. MS (El) m/e 306
(10), 158 (12), 157 (23), 142 (16), 141 (10), 125 (11), 123 (23), 91 (100), 77 (14), 65
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(17); HRMS (El) m/e calc'd for C i6H i9 0 2PS: 306.0843; found: 306.0835. GC: 
tR=14.4 min, purity 89.9%, impurity: If, 8.4%.
0-f-Butyl-O-isopropyI-P-phenyl-phosphonothioate (lh ).
Purified by flash chromatography eluting with hexane-EtOAc (10:1). Yield: 70%. 
1H NMR (250 MHz, CDC13) 6 1.11 (d, J=6.0 Hz, 3H, CHCH3), 1.35 (d, J=6.1 Hz, 
3H, C H C H 3), 1.55 (s, 9H, C (C H 3)3), 4.8 (m, 1H, C H (C H 3)2), 7.43 (m, 3H, Ph), 
7.92 (m, 2H, Ph); 31P NMR (101 MHz, CDCI3) 5 74.5. MS (El) m/e 272 (3), 217 (20), 
216 (48), 175 (100), 174 (86), 158 (23), 157 (35), 141 (40), 125 (15), 110 (78), 109
(21), 78 (15), 77 (41), 65 (11), 63 (12), 51 (15); HRMS (El) m /e  calc'd for 
C i3H 2 i0 2PS: 272.1000; found: 272.0993. GC: tR=10.42 min; purity 96.7%; 
impurities: If, 2.8%.
jV-BenzyI-0-isopropyl-P-phenyl-phosphonamidothioate (li).
Purified by flash chromatography eluting with hexane: EtOAc (8:1). Yield: 75%. 
!H NMR (250 MHz, CDC13) 8 1.36 (d, J=6.86 Hz, 6H, CH(CH 3)2), 3.26 (m, 1H, 
NH), 4.04 (m, 2H, CH2Ph), 4.98 (m, 1H, C H (C H 3)2), 7.46 (m, 3H, Ph), 7.89 (m, 
2H, Ph); 31P NMR (101 MHz, CDCI3) 5 72.3. MS (El) m/e 305 (7), 125 (10), 106 
(100), 91 (30); HRMS (El) m/e calc'd for C i6H20NOPS: 305.1003; found: 305.1007. 
GC: tR=15.5 min, purity 95.6%; impurities: If, 1.7%; Ph3P(S), 2.7%. 
lV,jV-Diethyl-0-isopropyl-.P-phenyl-phosphonainidothioate (lj).
Purified by pressure alumina chromatography eluting with hexane-EtOAc (50:1). 
Yield: 75%. !H NMR (250 MHz, CDCI3) 8 1.04 (t, J=7.0 Hz, 6H, 2 CH2C H 3), 1.34 
(d, J=5.8 Hz, 3H, C H C H 3), 1.37 (d, J=4.9 Hz, 3H, C H C H 3), 3.2 (m, 4H, 2 
C H 2CH3), 4.91 (m, 1H, C H (C H 3)2), 7.41 (m, 3H, Ph), 7.78 (m, 2H, Ph); 3IP NMR 
(101 MHz, CDCI3) 8 74.6. MS (El) m/e 271 (6), 158 (12), 125 (12), 72 (100); HRMS 
(El) m/e calc'd for C i3H 22NOPS: 271.1160; found: 271.1171. GC: tR= l 1.6 min; 
purity 98.4%; impurity, If 1.6%.
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jV-f-ButyI-0-isopropyI-P-phenyI-phosphonamidothioate (lk).
Purified by flash chromatography eluting with hexane-EtOAc (10:1) followed by 
recrystallization with hexane. Yield: 72%: m.p. 60-61 °C (hexane); *H NMR (250 
M Hz, CDC13) 8 1.18 (s, 9H, C (C H 3)3), 1.31 (d, J=6.0 Hz, 3H, C H CH 3), 1.44 (d, 
J=6.0 Hz, 3H, C H C H 3), 2.98 (d, Jph=7.9 Hz, 1H, NH), 5.0 (m, 1H, C H (C H 3)2), 
7.41 (m, 3H, Ph), 7.9 (m, 2H, Ph); 31P NMR (101 MHz, CDCI3) 8 68.2. MS (El) m/e 
271 (30), 256 (25), 180 (29), 157 (32), 156 (14), 140 (41), 124 (28), 110 (33), 109
(11), 78 (10), 77 (24), 72 (38), 63 (16), 58 (100), 57 (27), 51 (11). Analysis calc’d for 
C 13H 22NOPS: C,57.54; H, 8.17; N, 5.16; found: C, 57.41; H, 7.95; N, 5.15. GC: 
tR=l 1.7 min; purity 100%. The atomic coordinates for this structure have been deposited 
with the Cambridge Crystallographic Data Centre. The coordinates can be obtained, on 
request, from the Director, Cambridge Crystallographic Data Centre, 12 Union Road, 
Cambridge, CB2 1EZ, UK. (see section 2.3.4.1 for details of the x-ray structure 
analysis)
O-Isopropyl-P-pheny 1-S-phenyl-phosphonodithioate (II).
Purified by flash chromatography eluting with hexane-EtOAc (10:1). Yield: 83%. 
!H NMR (250 MHz, CDCI3) 8 1.35 (d, J=6.3 Hz, 3H, CH CH 3), 1.46 (d, J=6.1 Hz, 
3H, C H C H 3), 5.13 (m, 1H, C H (C H 3)2), 7.32 (m, 8H, Ph and SPh), 7.73 (m, 2H, 
Ph); 31p NMR (101 MHz, CDCI3) 8 88.7. MS (El) m/e 308 (10), 199 (24), 157 (100), 
110 (47), 109 (15), 77 (16), 63 (14); HRMS (El) m/e  calc’d for C 15H 17O P S 2: 
308.0458; found: 308.0444. GC: tR= 15.06 min; purity 93.6%; impurity: If, 3.4%. 
iV-f-butyl'O-f-butyl-P^methylphosphonothioate (lm ).
Product was purified by flash chromatography eluting with hexane-EtOAc (10:1). 
Yield: 61%. *H NMR (250 MHz, CDCI3) 8 1.30 (s, 9H, tBu), 1.58 (s, 9H, tBu), 1.88 
(d, JPh=5.2 Hz, 3H, CH3), 2.91 (bs, 1H, NH); 3*P NMR (101 MHz, CDCI3) 8 69.3. 
MS (El) m/e 223 (8), 168 (14), 167 (36), 152(100), 150 (12), 124(17), 112 (16), 111 
(16), 96 (22), 95 (16), 94 (31), 78 (29), 72 (84), 64 (14), 63 (11), 58 (75), 57 (84), 56
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(13), 55 (16); HRMS (El) m/e calc’d for C9H 22NOPS: 223.1160; found: 223.1172. 
GC: tR=8.2 min; purity 98%.
S-f-Butyl-O-methyl-P-methyl-phosphonothioate (In).
Purified by flash chromatography eluting with hexane-EtOAc (100:7). Yield: 
47%. IH NMR (250 MHz, CDCI3) 8 1.54 (s, 9H, /-Bu), 2.19 (d, JPH=13.5 Hz, 3H, 
CH3)), 3.72 (d, Jph=15.3 Hz, 3H, OCH3); 31P NMR (101 MHz, CDCI3) 8 98.8. MS 
(El) m/e 198 (9), 142 (57), 109 (100), 77 (24), 57 (53) GC: tR=7.8 min; purity: 80%; 
impurit: CH3P(S)(Sr-Bu)2, 13%. 31P NMR (101 MHz, CDC13) 8 63.7. MS (El) m/e 
256 (3), 200 (38), 144 (100), 111 (18), 110 (10), 79 (11), 57 (100); HRMS (El) m/e 
calc’d for C6H i5NOPS2: 198.0302; found: 198.0301. GC: tR= 10.5 min],
iV-BenzyI-O-isopropyl-iV-(0-isopropyI-P-phenyI-thiophosphonyI)-.P 
phenyl-phosphonamidothioate (5).
It was prepared according to the general procedure using 1 equiv of benzylamine.
The crude product was triturated with dichloromethane. The faster eluting band upon
flash chromatography [hexane-EtOAc (8:1)] was isolated and further purified by
recrystallization with hexane. Yield: 40%, m.p. 143 °C-144 °C. ’H NMR (250 MHz,
CDCI3) 8 1.06 (d, J=6.3 Hz, 6H, 2 CH CH 3), 1.16 (d, J=6.2 Hz, 6H, 2 C H CH 3), 4.78
(m, 2H, 2 C H (C H 3)2), 5.03 (m, 2H, CH2Ph), 7.25 (m, 11H, Ph); 31P NMR (101
MHz, CDCI3) 8 79.21. MS (FAB (glycerol)) m/e 504((M  + H)+). Analysis calc'd for
C25H3iN 0 2P2S2: C, 59.63; H, 6.20; N, 2.78; found: C, 60.32; H, 6.33; N, 2.69.
The atomic coordinates for this structure have been deposited with the Cambridge
Crystallographic Data Centre. The coordinates can be obtained, on request, from the
Director, Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge, CB2
1EZ, UK.
2.2.4.1. X-ray Structure Analysis
Diffraction data for lk  and 5 were collected on an Enraf-Nonius CAD4 
diffractom eter equipped with CuKqc radiation (X = 1.54184 A), and a graphite
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monochromator. Intensity data were measured by to-20 scans o f variable rate. For each 
compound, a quadrant of data was collected within the limits 2<0<75°. Data reduction 
included corrections for background, absorption, Lorentz, and polarization effects. 
Absorption corrections were based on psi scans. The structures were solved using 
direct methods and refined by full-matrix least squares, treating nonhydrogen atoms 
anisotropically, using the Enraf-Nonius MolEN programs.52 Hydrogen atoms were 
placed in calculated positions, except for the N-H hydrogen atom of lk , which was 
refined isotropically. Crystal data are: lk: C 13H22SPON, Mr=271.4, monoclinic space 
group P2i/c , a=9.441(l), b=20.378(2), c=9.099(l)A , P=116.933(7)°, V=1560.6(6)A3, 
Z=4, dc=1.155 g c m '3, T=24° C, p.(CuK<x)=26.8 c n r* . Of 3168 unique data, 2872
had I>3s(I) and were used in the refinement. Convergence was achieved with R=0.057 
and Rw=0.068. 5: C25H3 JS 2 P 2 0 2 N , M r=503.6, monoclinic space group P2f/n , 
a= 10.1440(6), b= 21.418(3), c=12.9213(7)A, p=107.653(5)°, V=2675.1(8)A3, Z=4, 
dc=1.250 g cm -3 , T=23° C, |i(C uK a)=30.9 cm '* O f 5418 unique data, 4026 had 
I>3a(I) and were used in the refinement. Convergence was achieved with R=0.043 and 
Rw=0.051.
Table 2.2. Fractional Atomic Coordinates and Equivalent Isotropic 
Thermal Parameters (A2) for lk
Atom X X z f i e a
S 0.75116(6) 0.25360(2) 0.59028(7) 4.33(1)
P 0.63864(5) 0.17084(2) 0.51993(6) 3.227(9)
0 0.7118(2) 0.11130(7) 0.6436(2) 4.33(3)
N 0.6289(2) 0.15106(8) 0.3427(2) 4.09(4)
C l 0.4422(2) 0.1723(1) 0.5045(3) 3.62(4)
C2 0.4038(3) 0.1433(1) 0.6191(3) 4.79(5)
C3 0.2500(3) 0.1475(2) 0.6006(4) 6.31(7)
C4 0.1355(3) 0.1815(2) 0.4688(4) 6.29(7)
C5 0.1731(3) 0.2106(2) 0.3565(4) 6.21(7)
C6 0.3257(3) 0.2066(1) 0.3728(3) 4.96(5)
C7 0.5579(3) 0.0946(1) 0.2297(3) 4.56(5)
C8 0.4281(4) 0 .1201(2) 0.0700(4) 7.8(1)
C9 0.6889(4) 0.0651(2) 0.1984(4) 7.44(8)
CIO 0.4919(4) 0.0439(1) 0.3027(4) 7.53(8)
C l l 0.8832(3) 0 .1022( 1) 0.7423(3) 5.33(6)
C12 0.9210(5) 0.1111(3) 0.9154(5) 11.7(1)
C13 0.9250(4) 0.0355(2) 0.7089(6) 10.2( 1)
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HI 0.663(3) 0.180(1) 0.298(3) 5.1(6)
H2 0.4826 0.1204 0.7105 6
H3 0.2233 0.1271 0.6784 8
H4 0.0303 0.1844 0.4565 8
H5 0.0938 0.2338 0.2662 8
H6 0.3510 0.2273 0.2942 6
H8a 0.3457 0.1385 0.0894 10
H8b 0.4702 0.1527 0.0263 10
H8c 0.3863 0.0850 -0.0065 10
H9a 0.7293 0.0975 0.1523 9
H9b 0.7718 0.0498 0.2993 9
H9c 0.6476 0.0294 0.1237 9
HlOa 0.5745 0.0281 0.4032 9
HlOb 0.4110 0.0631 0.3232 9
HlOc 0.4485 0.0084 0.2277 9
H ll 0.9429 0.1330 0.7150 6
H12a 0.8925 0.1542 0.9314 15
H12b 0.8634 0.0801 0.9452 15
H 12c 1.0316 0.1047 0.9821 15
H13a 0.8986 0.0317 0.5954 13
H13b 1.0356 0.0284 0.7734 13
H13c 0.8674 0.0037 0.7364 13
B eq = (87t2/3)IjSjUjjai*aj*ai*aj
Table 2.3. Bond Distances (A) for lk
S P 1.9416(7)
P 0 1.586(1)
P N 1.625(2)
P C l 1.796(2)
0 C ll 1.464(2)
N C7 1.487(3)
N HI 0.85(3)
Cl C2 1.383(4)
Cl C6 1.395(3)
C2 C3 1.386(4)
C3 C4 1.383(4)
C4 C5 1.361(6)
C5 C6 1.383(4)
C l C8 1.507(4)
C l C9 1.514(5)
C l CIO 1.508(5)
C l l C12 1.462(6)
C l l C13 1.485(5)
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Table 2.4. Bond Angles (°) for lk
s P 0 115.70(5) C2 C3 C4 120.1(3)
s P N 108.63(7) C3 C4 C5 120.1(3)
s P Cl 113.79(7) C4 C5 C6 120.5(2)
0 P N 109.01(9) Cl C6 C5 120.0(3)
o P Cl 99.80(9) N Cl C8 108.4(2)
N P Cl 109.56(9) N Cl C9 106.7(2)
P 0 C ll 122.5(2) N Cl CIO 111.9(2)
P N Cl 133.2(2) C8 Cl C9 109.4(3)
P N HI 116(2) C8 Cl CIO 110.1(2)
C7 N HI 111(2) C9 Cl CIO 110.4(2)
p Cl C2 123.3(1) O C ll C12 107.9(3)
p Cl C6 117.4(2) O C ll C13 108.2(2)
C2 Cl C6 119.2(2) C12 C ll C13 112.1(3)
Cl C2 C3 120.0(2)
Table 2.5. Torsion Angles (°) for lk
S P O C ll -36.19(0.18)
N P O C ll 86.54(0.18)
Cl P O C ll -158.70(0.17)
s P N Cl -179.57(0.19)
0 P N Cl 53.56(0.24)
Cl P N Cl -54.73 (0.23)
s P Cl C2 -104.58(0.19)
s P Cl C6 72.97(0.18)
0 P Cl C2 19.28(0.21)
0 P Cl C6 -163.17(0.17)
N P Cl C2 133.62(0.19)
N P Cl C6 -48.83(0.20)
P O C ll C12 113.52(0.28)
P O C ll C13 -124.90(0.24)
P N Cl C8 116.79(0.26)
P N Cl C9 -125.52(0.23)
P N Cl CIO -4.78(0.34)
P Cl C2 C3 178.72(0.22)
C6 Cl C2 C3 1.21(0.37)
P Cl C6 C5 -178.63(0.21)
C2 Cl C6 C5 -0.98(0.36)
Cl C2 C3 C4 -0.85(0.45)
C2 C3 C4 C5 0.24(0.52)
C3 C4 C5 C6 0.00(0.69)
C4 C5 C6 Cl 0.38(0.44)
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Table 2.6. Fractional atomic coordinates and equivalent isotropic thermal
parameters (A2) for 5
Atom X X z fieg
SI 0.29870(8) 0.49049(4) 0.23974(7) 5.47(2)
S2 0.58691(7) 0.72219(4) 0.36038(6) 4.31(2)
P i 0.23709(7) 0.57547(3) 0.24213(6) 3.33(1)
P2 0.42891(6) 0.68431(3) 0.25530(5) 3.05(1)
01 0.1876(2) 0.61047(8) 0.1297(1) 3.61(4)
0 2 0.3057(2) 0.73003(8) 0.2022( 1) 3.65(4)
N 0.3610(2) 0.6258(1) 0.3114(2) 3.14(4)
C l 0.4264(3) 0.6074(1) 0.4271(2) 3.98(6)
C2 0.3566(3) 0.6317(2) 0.5064(2) 4.20(6)
C3 0.3416(4) 0.5926(2) 0.5868(3) 6.70(9)
C4 0.2836(4) 0.6164(2) 0.6642(3) 9.1(1)
C5 0.2434(4) 0.6760(2) 0.6625(3) 8.9(1)
C6 0.2584(4) 0.7151(2) 0.5835(3) 7.6(1)
C7 0.3152(3) 0.6925(2) 0.5055(3) 5.80(8)
C8 0.0961(3) 0.5825(1) 0.2991(2) 3.79(6)
C9 0.0429(3) 0.5317(2) 0.3371(3) 5.40(8)
CIO -0.0698(3) 0.5394(2) 0.3768(3) 7.1(1)
C l l -0.1263(3) 0.5967(2) 0.3775(3) 7.1(1)
C12 -0.0753(3) 0.6471(2) 0.3391(3) 7.2(1)
C13 0.0367(3) 0.6402(2) 0.2998(3) 5.61(8)
C14 0.4706(2) 0.6514(1) 0.1411(2) 3.70(5)
CIS 0.5470(3) 0.5976(2) 0.1554(3) 5.48(8)
C16 0.5876(4) 0.5735(2) 0.0695(3) 7.6(1)
C17 0.5529(4) 0.6037(2) -0.0276(3) 7.7(1)
C18 0.4776(4) 0.6573(2) -0.0418(3) 7.1(1)
C19 0.4356(3) 0.6817(2) 0.0419(2) 5.27(7)
C20 0.0835(3) 0.5827(2) 0.0366(2) 4.93(7)
C21 -0.0427(4) 0.6234(3) 0.0102(3) 8.5(1)
C22 0.1426(4) 0.5781(2) -0.0544(3) 9.4(1)
C23 0.2981(3) 0.7960(1) 0.2299(2) 3.85(6)
C24 0.1556(3) 0.8076(2) 0.2352(3) 6.9(1)
C25 0.3352(4) 0.8353(2) 0.1471(3) 6.57(9)
H la 0.5188 0.6224 0.4489 5
H lb 0.4268 0.5631 0.4307 5
H3 0.3700 0.5501 0.5896 8
H4 0.2725 0.5894 0.7193 11
H5 0.2046 0.6910 0.7161 11
H 6 0.2302 0.7575 0.5817 9
H7 0.3253 0.7198 0.4505 7
H9 0.0823 0.4914 0.3365 7
H10 -0.1069 0.5043 0.4034 9
HI 1 -0.2024 0.6015 0.4051 9
H12 -0.1161 0.6870 0.3391 9
H13 0.0727 0.6755 0.2731 7
H15 0.5720 0.5766 0.2234 7
H16 0.6397 0.5359 0.0788 9
H17 0.5813 0.5872 -0.0858 10
H18 0.4537 0.6781 -0.1098 9
H19 0.3829 0.7191 0.0314 6
H20 0.0578 0.5418 0.0514 6
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H21a -0.0769 0.6250 0.0708 11
H21b -0.0193 0.6643 -0.0065 11
H21c -0.1117 0.6066 -0.0506 11
H22a 0.2220 0.5519 -0.0339 12
H22b 0.0757 0.5608 -0.1159 12
H22c 0.1681 0.6185 -0.0718 12
H23 0.3617 0.8066 0.2982 5
H24a 0.1381 0.7813 0.2889 8
H24b 0.1470 0.8500 0.2533 8
H24c 0.0905 0.7986 0.1665 8
H25a 0.4269 0.8258 0.1475 8
H25b 0.2729 0.8267 0.0771 8
H25c 0.3294 0.8781 0.1639 8
(87t2/3)ZjZjUijaj * „ 3j ®i*3j
Table 2.7. Bond Distances (A) for 5
SI PI 1.928(1) C6 C l 1.390(6)
S2 P2 1.9366(9) C8 C9 1.371(5)
PI 01 1.575(2) C8 C13 1.376(4)
PI N 1.691(2) C9 CIO 1.397(5)
PI C8 1.802(3) CIO C ll 1.356(6)
P2 02 1.572(2) C l l C12 1.355(6)
P2 N 1.695(2) C12 C13 1.386(5)
P2 C14 1.797(3) C14 C15 1.371(4)
01 C20 1.464(3) C14 C19 1.384(4)
02 C23 1.465(3) C15 C16 1.395(6)
N C l 1.492(3) C16 C17 1.360(5)
C l C2 1.503(4) C17 C18 1.360(6)
C2 C3 1.378(5) C18 C19 1.380(5)
C2 C7 1.369(5) C20 C21 1.500(5)
C3 C4 1.401(6) C20 C22 1.476(6)
C4 C5 1.339(7) C23 C24 1.489(5)
C5 C6 1.364(6) C23 C25 1.496(5)
Table 2.8. Bond Angles (°) for 5
SI PI 01 116.67(8) C3 C4 C5 121.8(4)
SI PI N 114.68(8) C4 C5 C6 119.7(4)
SI PI C8 112.8( 1) C5 C6 C l 119.6(4)
01 PI N 99.4(1) C2 C l C6 121.3(3)
01 PI C8 105.4(1) PI C8 C9 121.8(2)
N PI C8 106.5(1) PI C8 C13 118.8(2)
S2 P2 02 115.11(7) C9 C8 C13 119.4(3)
S2 P2 N 111.52(7) C8 C9 CIO 119.5(3)
S2 P2 C14 112.89(9) C9 CIO C l l 120.3(4)
02 P2 N 106.0(1) CIO C ll C12 120.6(4)
02 P2 C14 103.9(1) C l l C12 C13 119.7(4)
N P2 C14 106.8(1) C8 C13 C12 120.5(3)
PI 01 C20 120.9(2) P2 C14 C15 118.9(2;
P2 02 C23 126.0(1) P2 C14 C19 121.3(2)
(table con'd)
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PI N P2 125.3(1) C15 C14 C19 119.7(3)
PI N C l 113.3(2) C14 C15 C16 119.7(3)
P2 N C l 120.6(2) C15 C16 C17 120.2(4)
N C l C2 115.7(2) C16 C17 C18 120.2(4)
C l C2 C3 119.1(3) C17 C18 C19 120.6(3)
C l C2 C7 122.0(3) C14 C19 C18 119.7(3)
C3 C2 C7 118.7(3) 01 C20 C21 107.7(3)
C2 C3 C4 118.9(4) 01 C20 C22 108.4(3)
C21 C20 C22 112.5(3) 02 C23 C25 108.9(3)
Table 2.9. Torsion Angles (°) for 5
SI PI Ol C20 52.18(0.21) P2 02 C23 C24 -136.98(0.23)
N PI 01 C20 175.99(0.20) P2 0 2 C23 C25 99.96(0.26)
C8 PI Ol C20 -73.83(0.22) PI N C l C2 -88.71(0.25)
SI PI N P2 111.71(0.14) P2 N C l C2 101.28(0.25)
SI PI N Cl -57.74(0.19) N C l C2 C3 138.21(0.28)
01 PI N P2 -13.49(0.17) N C l C2 C l -45.97(0.38)
Ol PI N Cl 177.06(0.17) C l C2 C3 C4 176.41fO.31)
C8 PI N P2 -122.79(0.16) C l C2 C3 C4 0.45(0.50)
C8 PI N Cl 67.76(0.20) C l C2 C l C6 -176.05(0.30)
SI PI C8 C9 0.84(0.27) C3 C2 C l C6 -0.22(0.49)
SI PI C8 C13 -176.21(0.21) C2 C3 C4 C5 -0.45(0.59)
01 PI C8 C9 129.22(0.24) C3 C4 C5 C6 0.18(0.61)
Ol PI C8 C13 -47.83(0.26) C4 C5 C6 C l 0.06(0.61)
N PI C8 C9 -125.80(0.24) C5 C6 C l C2 -0.05(0.58)
N PI C8 C13 57.14(0.26) PI C8 C9 CIO -177.63(0.25)
S2 P2 02 C23 -3.74(0.22) C13 C8 C9 CIO -0.59(0.46)
N P2 02 C23 119.99(0.20) PI C8 C13 C12 177.51(0.27)
C14 P2 02 C23 -127.68(0.21) C9 C8 C13 C12 0.38(0.47)
S2 P2 N PI -171.17(0.11) C8 C9 CIO C ll 0.16(0.50)
S2 P2 N Cl -2.43(0.21) C9 CIO C ll C12 0.50(0.55)
02 P2 N PI 62.88(0.17) CIO C l l C12 C13 -0.71(0.56)
02 P2 N Cl -128.38(0.19) C ll C12 C13 C8 0.27(0.53)
C14 P2 N PI -47.41(0.18) P2 C14 C15 C16 -176.00(0.26)
C14 P2 N Cl 121.33(0.20) C19 C14 C15 C16 -0.55(0.47)
S2 P2 C14 C15 72.44(0.25) P2 C14 C19 C18 175.53(0.27)
S2 P2 C14 C19 -102.94(0.24) C15 C14 C19 C18 0.18(0.49)
02 P2 C14 C15 -162.20(0.23) C14 C15 C16 C17 0.66(0.54)
02 P2 C14 C19 22.42(0.27) C15 C16 C17 C18 -0.40(0.58)
N P2 C14 C15 -50.48(0.26) C16 C17 C18 C19 0.03(0.68)
N P2 C14 C19 134.14(0.25) C17 C18 C19 C14 0.09(0.56)
P I Ol C20 C21 114.68(0.26)
PI Ol C20 C22 -123.31(0.28)
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2.2.5. Synthesis and Characterization of a-Amino-Alkyl-ff-Phosphinates
The following compounds were obtained and used in the synthesis of compounds 
7c and 8c.
Ammonium phosphinate (7a).41
It was prepared by carefully adding a 50% aqueous solution of commercially 
available hypophosphorus acid (13.2 g, 0.2 mol) to 0.880 M aqueous ammonia (7.7 g, 
0.22 mol). Water was removed with rotary evaporation, and the white crystals were dried 
over P2O5 under high vacuum. Yield: 16 g (96.4 %).
Tritylamine (8a).53
It was prepared by stirring solid trityl chloride (27.88 g, 0.1 mol) with an excess 
o f conc. aqueous ammonia (150 mL, 2.22 mol) at room temperature for 2 days. The 
white solid formed was collected by suction filtration, dissolved in 500 mL ether, washed 
with sat. NaHCC>3 (2 x 150 mL), H2O (150 mL) and dried (Na2S0 4 ). The solvent was 
evaporated and the product was dried under high vacuum. Yield: 21.7 g (87 %). mp 95 
°C, lit. mp 96 °C. 1H NMR (250 MHz, CDCI3) d  2.48 (brs, 2H, NH2), 7.28 (s, 15H, 3 
Ph).
N-Trityl-2-methylpropanimine (7b).5 3
A mixture of tritylamine 8a (12.97 g, 0.050 mol), toluene (50 mL), and 
isobutyraldehyde (4.0 g, 0.055 mol) is heated to reflux in a Dean-Stark distillation device 
with a calibrated receiver. When the calculated amount o f H2O (0.9 mL) has separated, 
the reaction mixture is evaporated to give a practically pure product, which can be 
recrystallized from MeOH. Yield: 15.7 g (95%). mp 89 °C, lit. mp 88 °C-90 °C. *H NMR 
(250 MHz, CDCI3) d  1.02 (d, 6H, 2 CH3), 2.5 (m, 1H, C H (C H 3)2), 7.08 (d, 1H, 
CH), 7.15 (m, 15H, 3 Ph).
N-Tritylmethanimine (8b).53
A mixture of tritylamine 8a (12.97 g, 0.050 mol), toluene (50 mL), and aqueous 
formaldehyde (8.4 g, 0.1 mol) is vigorously stirred at room temperature for 24 h. Then,
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
water is removed by stirring the mixture with Na2S0 4  (20 g) for 15 min. The solid 
material is filtered off and washed with toluene (30 mL); the filtrate is evaporated under 
reduced pressure to give a practically pure crystalline product. Yield: 12.2 g (90%). mp: 
132-135 °C, lit. mp 135 °C-136 °C. }H NMR (250 MHz, CDCI3) d  7.02 (d, 1H, CH), 
7.26 (m, 15H, 3 Ph), 7.77 (d 1H, CH).
B is(trim ethy lsily l) p h o sp h o n ite54
Bis(trimethylsilyl) phosphonite was prepared by heating together ammonium 
phosphinate (2.5 g, 30.1 mmol) and hexamethyldisilazane (6.3 mL, 30.1 mmol) at 100- 
110 °C under nitrogen for 30 min in a lOOmL 3-neck flask fitted with a septum and 
condenser. After 30 min 10 mL of dry THF was injected and after 1 hour additional 
hexamethyldisilazane (2 mL, 9.54 mmol) was added. The mixture was refluxed for 
another 1 h.
l-A m ino-2 -isop ropy lphosph in ic  ac id  (7c).40' 41
CHCI3 was added from a syringe to the in situ generated bis(trimethylsilyl 
phosphonite (18.8 mmol) at 0 °C under N2 and stirring was continued for 5 min. A 
solution of Af-trityl-2-methylpropanimine 7b (5.9 g, 18.8 mmol) in CHCI3 (20 mL) was 
then gradually injected at 0 °C and stirring continued at room temperature for 12 h. The 
solvent was removed under reduced pressure, the residue was dissolved in 1 M HC1 in 
MeOH (30 mL) and refluxed for 15 min. The solvent was evaporated under reduced 
pressure, H2O (30 mL) was added and the mixture was extracted with diethyl ether (3 x 
10 mL). The aqueous layer was evaporated under reduced pressure, the residue 
solubilized in anhydrous EtOH (30 mL) and treated with an excess of propylene oxide. 
The precipitated product was isolated by suction, washed with EtOH and dried under 
vacuum.Yield: 1.44 g (56% ). »H NM R (250 Hz, D20 ) d 1.09-1.13 (2d, 6H, 
C H (C H 3)2), 2.26 (m, 1H, C H (C H 3)2), 2.95 (m, 1H, C H (C 3H7)), 7.10 (d, Jph=535 
Hz, 1H, P-H); 31P NMR (101 MHz, CDCI3) d 18.6.
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1-A m inom ethanephosphin ic  acid  (8c ).40
THF was added from a syringe to the in situ generated bis(trim ethylsilyl 
phosphonite (30.1 mmol) at 0 °C under N2 and stirring was continued for 5 min. A 
solution of N-tritylmethanimine 8b (30.1 mmol, 8.16 g) in THF (50 mL) was gradually 
injected at 0 °C and stirring continued at room temperature for 12 h. It becomes a clear 
solution. If there are insoluble impurities in the solution is better to filter them before 
evaporating the solvent. The solvent is evaporated under reduced pressure, the oily 
residue was dissolved in 1M HC1 in MeOH (48 mL) and refluxed for 15 min. The solvent 
was evaporated under reduced pressure, H 2O (48 mL) was added and the mixture was 
extracted with CHCI3 (3 x 20 mL). The aqueous layer was evaporated under reduced 
pressure. Product appears as a yellow oil. Yield: 3.2 g (80%) (hydrochloride salt o f 8c).
NMR (250 MHz, D20 )  d  2.99 (d. 2H, CH2), 7.12 (d, JPH= 542 Hz, 1H, P-H)); 31P 
NMR (101 MHz, D20 )  d  14.6.
l-A m in o -l-m e th y le th an ep h o sp h o n o u s  ac id  (9c).55
The following compounds were obtained and used in the synthesis o f compound
(9c).
M eth y le th y lid en eb en zh y d ry lam in e  (9a).
Dry acetone (10 mL, 0.14 mol) and benzhydrylamine (17.24 mL, 0.1 mol) were 
refluxed in toluene (80 ml) for 15 hours with molecular sieves 4A (25 g). The solid 
material was filtered and the filtrate was refluxed in the presence o f 5% o f the 
stoichiometric amount of Bu2SnCl2 (1.51 g, 5 mmol) for an additional 15 hours adding 
again an excess o f acetone (100 mL, 1.4 mol). The use of this catalyst was reported by 
J.C. Pommier et al. for the synthesis o f imines under strictly neutral conditions.42 The 
solid that remained after refluxing was removed by filtration and the filtrate was 
concentrated under vacuum. Product appears as a yellow oil. Yield: 18.3 g (82%). *H 
NMR (250 MHz, CDCI3) d  1.92 (s, 3H, CH3), 2.15 (s, 3H, CH3), 5.63 (s, 1H, CH), 
7.28 (m, 10H, 2 Ph); MS (FAB (MNBA)) m/e 224.2 ((M + H)+).
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l-B en zh y d ry lam in o -l-m e th y le th an ep h o sp h o n o u s  ac id  (9 b ).55
The method used for the preparation o f this compound was the one reported by 
Dingwall et a l.41 for the synthesis o f  other phosphinate amino acids. 100% 
Hypophosphorus acid56 (5.4 g, 0.082 mol) in ethanol (41 mL) was added to the crude 
methylethylidenebenzydrylamine 9a (0.082 mol, 18.29 g) in ethanol (123 mL) and the 
mixture refluxed for 1 h and then cooled. Evaporation of the solvent gave a white solid 
that was filtered off, washed with ethanol and then ether, and then dried. Yield: 20.5 g 
(86%); mp. 195 °C-196 °C, lit.55 mp 207 °C-210 °C. lH NMR (200 MHz, CDCI3) d  
2.46 (brs, 6H, 2CH3), 6.98 (d, JPH=546.5 Hz, 1H, P-H), 7.4 (m, 10H, 2Ph); 31P 
NMR (101 MHz, CDCI3) d  34.0; MS (FAB (glycerol)) m/e 289.9 ((M + H)+). 
1 -A m in o -l-m eth y le th an ep h o sp h o n o u s ac id  (9c).
A portion of 9b (16 g, 0.055 mol) was heated together with an excess o f 48% 
hydrobromic acid (5 times by weight) at 100 °C for 2 hours. The solution was fitrated to 
separate the solid formed. The solvent was evaporated from the filtrate and the residue 
taken up in water (50 mL). The aqueous solution was washed with ether (3 x 20 mL) to 
remove diphenylbromide and then evaporated to dryness. A yellowish oil was obtained 
as product. The oily residue o f 1-amino-l-methylethanephosphonous acid hydrobromide 
(11.29 g) was dissolved in ethanol (10 ml/g) and propylene oxide added dropwise until 
precipitation started. The mixture was allowed to stand until complete precipitation and 
the white solid was filtered off, washed with ethanol and then ether, and then dried. 
Yield: 2.52 g (37%); mp 244 °C-246 °C, lit.55 mp 242 °C. !H NMR (300 MHz, D 20) d  
1.38(s, 3H, CH3), 1.42 (s, 3H, CH3), 6.85 (d, JPH=526 Hz, 1H, P-H); 3 lp  NMR (101 
MHz, D20 )  d  25.7; MS (FAB (NBA)) m/e 124.1 ((M + H)+).
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4 3
l-Amino-2'phenyIethanephosphonous acid (10c).4 1
The following compounds were obtained and used in the synthesis o f compound
10c.
jV-(Diphenylmethyl)ammonium phosphonite (10a)
Hypophosphorus acid (1.99 g, 30 mmol) was dissolved in ethanol (75 mL). 
Benzhydrylamine (5.2 mL, 30 mmol) was then added to the reaction flask and stirred for 
20 min. The solvent was removed with rotary evaporation, and the white phosphite 
crystals were dried under high vacuum. Yield: 7.4 g (99%). 31P NMR (EtOH) d: 1.24. 
l-Benzhydrylamino-2-phenyIethanephosphonous acid (10b).
The phosphite salt 10a (7.47 g, 30 mmol) was dissolved in dioxane (50 mL) 
with application of heat (100 °C). Phenylacetaldehyde (5.2 mL, 30 mmol) was added 
under N2. The reaction was left to stir until the clear solution turned to a yellow slushy 
mixture. 100 mL of dioxane was then removed using a Dean-Stark receiver. The reaction 
mixture was allowed to cool and then diluted with absolute ethanol (50 mL). The white 
precipitate was collected by filtration and washed with ethanol, ether and dried under 
vacuum to give a white solid. Yield: 1.8 g (19 %). !H NMR (250 MHz, D2O) d  2.72, 
2.3 (m, 1H each, PhCH2), 3.17 (s, 1H, Ph2C H ), 3.44 (q, lh , PHCH2C H , J=6.89 
Hz), 5.06 (s, 1H, NH), 6.9 (brd, JPH=515Hz, 1H, P-H), 7.26 (m, 15H, 3Ph); 3*P 
NMR (101 MHz, D20 )  d  30.0.; MS (FAB (NBA)) m/e 352.5 ((M + H)+). 
l-Amino-2-phenylethanephosphonous acid (10c).
An excess o f 48% HBr (15 mL) was added to a flask containing the phosphonous 
acid 10b (3.040 g, 8.67 mmol). The mixture was refluxed for 2 hours. The reaction 
solution was taken up in water (25 mL) and washed with ether (3 x 10 mL). Rotary 
evaporation removed the water and the resulting solid was dissolved in ethanol (50 mL). 
Propylene oxide was then added until precipitation started. The white precipitate was 
collected by filtration and washed with ethanol and ether then dried under high vacuum. 
Yield: 900 mg (56%). lH NMR (250 MHz, D20 )  d  2.88 (m, 1H, CH), 3.36 (m, 2H,
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CH2), 7.05 (d, JpH=535 Hz, 1H, P-H), 7.38 (m, 5H, Ph); 31P NMR (101 MHz, D20 )  
d  18.5.;MS (FAB (NBA)) m/e 186.2 ((M + H)+).
2.2.6. Synthesis and Characterization of Protected a-Amino-Alky 1-/7- 
Phosphinates
l-[iV-(r-Butoxycarbonyl)amino]-2-isopropylphosphinic acid (7d).
Following Bartlett and Sampson's procedure,18 l-amino-2-isopropylphophinic 
acid 7c (2.06g, 15mmol), 2-[[(r-butoxycarbonyl)oxy]imino]-2-phenylacetonitrile (Boc- 
ON®; 4.10g, 16.6mmol), Et3N (3.1ml, 22.2mmol), and DMF (4.5mL) were heated at 
70 °C for 12 h. The Et3N and DMF were removed under high vacuum and the oil-like 
residue was diluted with water (65 mL), adjusted to pH 7.5 by addition of 4N NaOH. 
and washed with EtOAc (4 x 30ml). Then the aqueous layer was acidified to pH 1 with 
12N HC1 and extracted with CHCI3 (4 x 30ml). The combined CHCI3 layers were dried 
over Na2S04  and concentrated in vacuo to produce l-[Af-(r-butoxycarbonyl)amino]-2- 
isopropylphosphinic acid 7d as a yellow oil. Yield: 3.09 g (88%). {H NMR (250 Hz, 
C D C I3) d 1.05 (m, 6H, C H (C H 3)2), 1.45 (s, 9H, COOt-Bu), 2.22 (m, 1H, 
C H (C H 3)2), 3.79 (m, 1H, C H (C 3H 7)), 4.97 (d, JNH=10.0 Hz, 1H, NH) 7.04 (d, 
JPH=560 Hz, 1H, P-H); 31P NMR (101 MHz, CDCI3) d 28.6, 29.7. 
l-[7V-(9-fFluorenylmethoxycarbonyl)£imino]-methanephosphinic acid (8d).
The crude salt of 1-aminomethanephosphinic acid hydrochloride 8c (2.9 g, 30.1 
mmol) was dissolved in water (20 mL), the pH o f the solution adjusted to 9.5 with 4N 
NaOH and the mixture cooled to 4 °C. 9-Fluorenylmethyl chloroformate (Fmoc-Cl) (8.5 
g, 33.1 mmol) in 20 ml dioxane was added. The mixture was stirred for 6 hours at 4 °C 
while the pH was mantained at 9-9.5 by periodic addition of 4N NaOH. Then the mixture 
was allowed to warm to room temperature and washed three times with diethyl ether. The 
aqueous layer was cooled in an ice bath and acidified with 6 N HC1 to pH= 1.5-2. The 
white precipitate formed was collected by filtration and dried under vacuum. Yield: 9.54 g 
(59% ). NMR (250 MHz, CDC13) d  3.57 (dd, 2H, C H 2 ). 4.15 (t, 1H,
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C H C H 2OCO), 4.38 (d, 2H, CH CH 2OCO), 7.07 (d, JPH= 579.3, 1H, P-H), 7.31 (m, 
4H, fluorenyl), 7.53 (d, 2H, fluorenyl), 7.72 (m, 2H, fluorenyl); 31P NMR (101 MHz, 
CDCI3) d  28.7. MS (FAB (glycerol)) m/e 318.2 ((M + H)+).
l-(7V-(9-FIuorenylmethoxycarbonyl)ainino]-l-inethyIethanephosphinic 
acid (9d).
Compound 9c (550mg, 4.5 mmol) was dissolved in water (4.5 mL), the pH of 
the solution adjusted to 9.5 with 4N NaOH and the mixture cooled to 4 °C. Fmoc-Cl 
(3.78 g, 14.75 mmol) in 4.5 mL dioxane was added. The mixture was stirred for 6 hours 
at 4 °C while the pH was mantained at 9-9.5 by periodic addition of 4N NaOH. Then the 
mixture was allowed to warm to room temperature and washed three times with ether. 
The aqueous layer was cooled in an ice bath and acidified with 6 N HC1 to pH= 1.5-2. 
The white precipitate was collected by filtration and dried under vacuum. Yield: 1.54 g 
(54%); mp. 194 °C. >H NMR (250 MHz, CDCI3) d  1.43 (s, 3H, CH3), 1.49 (s, 3H, 
C H 3), 4.2 (t, 1H, CH fluorenyl), 4.44 (d, 2H, CH2 fluorenyl), 4.96 (brs, 1H, NH),
7.12 (d, Jph  = 582 Hz, 1H, P-H), 7.35 (m, 4H, fluorenyl), 7.57 (d, 2H, fluorenyl),
7.77 (m, 2H, fluorenyl); 31P NMR (101 MHz, CDC13) d  31.2 ; MS (FAB (glycerol)) 
m/e 345.9 ((M + H)+).
l-[iV-(9-FluorenylmethoxycarbonyI)amino]-2-phenylethanephosphinic 
acid (10d).43
The phosphinate amino acid 10c (0.3 g, 1.62 mmol) was dissolved in H 2O (4 
mL). The pH was adjusted to 9 using 4N NaOH. This solution was brought to O °C, at 
which point a solution of Fmoc-Cl (0.470 g, 1.782 mmol) dissolved in dioxane (2 mL) 
was added over a period of 15 minutes. The reaction stirred at 0 °C and the pH was 
periodically checked and adjusted to 9. After 6 hours the reaction mixture was allowed to 
warm to room temperature. It was then extracted with ether ( 2 x 3  mL). The aqueous 
phase was added at 0 °C to 6N HC1 (10 mL). The white precipitate was collected by
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filtration and dried. Yield is 55% (0.36 g). mp 214-216 °C, lit.43 mp 184 °C-185 °C; 
NMR (250 MHz, CDCI3) d  2.78, 3.01 (m, 1H each, PhCH2), 3.45 (brs, 1H, OH), 3.79 
(t, 1H, CHCH2Ph), 4.09 (m, 3H, CH fluorenyl + CH2), 6.87 (d, Jph=535, 1H, P-H),
7.32 (m, 9H, C6H 5 + 4H fluorenyl), 7.62 (d, 2H, 2H fluorenyl), 7.81 (d, 1H, NH), 
7.88 (d, 2H, 2H fluorenyl); 31P NMR (101 MHz, CDCI3) d  27.16; MS (FAB (MNBA)) 
m/e 408.5 ((M + H)+).; Analysis calc’d for C23H22N 0 4P: C, 67.79; H, 5.45; N, 3.44; 
found: C, 67.58; H, 5.47; N, 3.31.
2.2.7. Synthesis and C h arac te riza tio n  o f P ro tec ted  a-A m ino-A Ikyl-FT- 
Phosphinates E sters
l-[iV -(r-B u to x y carb o n y l)a in in o ]-2 -iso p ro p y lp h o sp h in ic  acid , t-b u ty l e s te r  
(7).
According to the procedure described by Karanewsky and Badia,44 DCC (0.91 g,
4.2 mmol) and DMAP (0.05 g, 0.4 mmol) were added to a solution o f protected 
1-aminoisopropylphosphinic acid 7d (0.95 g, 4.0 mmol) and r-BuOH (0.31 g, 4.4 
mmol) in dry THF (10ml). After stirring at room temperature overnight, the mixture was 
diluted with EtOAc (30ml), filtered and washed successively with 5% KHSO4 (20ml), 
saturated NaHCC>3 (20ml) and saturated NaCl solutions (20ml). The organic phase was 
evaporated to give a white solid (0.80 g, 70%). The crude product 7 was purified by 
alumina chromatography with hexane-EtOAc (2:1) to provide a solid (0.67 g, mp 71-73 
°C). Final yield: 59%. 'H  (300 MHz, CDCI3) d 1.04-1.24 (m, 6H, C H (C H 3)2), d 
1.44, 1.45 (2s, 9H, COOfBu), 1.50, 1.51 (2s, 9H, OrBu), 2.17-2.28 (m, 1H, 
C H (C H 3)2), 3.69, 3.80 (2m, 1H, C H (C 3H7)), 4.72 (d, J=10.5 Hz, -0.5H , NH), 4.82 
(d, J=10.2 Hz, -0 .5H , NH), 7.14 (d, JPH=539.1 Hz, -0 .5H , P-H), 7.20 (d, 
JPH=537.9 Hz, -0.5H , P-H); 31P NMR (121 MHz, CDCI3) d 24.20, 24.99. Analysis 
calc'd for C i3H 28N 0 4P: C, 53.23; H, 9.62; N, 4.77; found: C, 53.49; H, 9.47; N,
5.00.
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l>[iV-(9-FluorenylmethoxycarbonyI)ainino]-methanephosphinic acid,
benzyl e s te r  (8).
To a solution of compound 8d  ( 126.8 m g, 0.4 mmol) and benzyl alcohol 
(0.043 mL, 0.42 mmol) in dry CH2CI2 (1.0 mL) at room temperature under nitrogen, 
was added DCC (90.8 mg, 0.44 mmol) and DMAP (5 mg, 0.04 mmol). After stirring at 
room temperature for 24 hours the mixture was filtered, diluted with EtOAc (5 mL) and 
washed succesively with 5% KHSO4 (2 mL), saturated NaHC03 (2 mL) and saturated 
NaCl solutions (2 mL), dried over Na2SC>4 and evaporated to dryness, to give a white 
powder. Yield: 129 mg (79.1%); lH NMR (250 MHz, CDCI3) d  3.56 (m, 2H, CH2),
4.12 (m, 1H, CH fluorenyl), 4.43 (d, 2H, CH2OCO), 5.10 (m, 3H, NH +  OCH2Ph),
7.15 (d, JPH= 563.4, 1H, P-H), 7.27 (m, 9H, CH2Ph + 4H fluorenyl), 7.55 (d, 2H, 
fluorenyl), 7.77 (d, 2H, fluorenyl); 3 lp  NMR (101 MHz, CDCI3) d  30.6. MS (FAB 
(MNBA)) m/e 408.3 ((M + H)+).
l-[A r-(9 -F lu o ren y lm e th o x y c a rb o n y I)a m in o ]- l-m e th y Ie th a n ep h o sp h in ic  
ac id , benzyl este r (9).
To a solution of compound 9d (1.035 g, 3 mmol) and benzyl alcohol (0.326 
mL, 3.15 mmol) in dry CH2CI2 (7.5 mL) at room temperature under nitrogen, was added 
DCC (0.681 g, 3.3 mmol) and DMAP (36.7 mg, 0.3 mmol). After stirring at room 
temperature for 24 hours the mixture was filtered, diluted with EtOAc (25 mL) and 
washed succesively with 5% KHS0 4 (1 5  mL), saturated NaHCC>3(15 mL) and 
saturated NaCl solutions (15 mL), dried over Na2SC>4 and evaporated to dryness, to give 
a white powder. Yield: 1.16 g (89 %); m.p. 125-135 °C; *H NMR (250 MHz, CDCI3) d  
1.45 (m, 6H, 2CH3), 4.20 (m, 1H, CH fluorenyl), 4.41 (d, 2H, CH2OCO), 4.91 (brs, 
1H, NH), 5.12 (m, 2H, OCH2Ph), 7.36 (m, 9H, CH2Ph + 4H fluorenyl), 7.38, (d, 
JpH= 578.5, 1H, P-H), 7.56 (d, 2H, fluorenyl), 7.76 (d, 2H, fluorenyl); 31P NMR (101 
MHz, DMSO) d  37.7. MS (FAB (glycerol)) m/e 436.4 ((M + H)+); HRMS (FAB 
(MNBA)) m/e calc'd for C25H26NO4 ((M + H)+): 436.1599; found: 436.1691.
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l-[iV-(9-FIuorenyImethoxycarbonyI)amino]-2-phenyIethanephosphinic 
acid, benzyl ester (10).43
To a solution o f compound lOd (2.0 g, 4.91 mmol) and benzyl alcohol ( 0.56 
mL, 5.4 mmol) in dry CH2CI2 (15 mL) at room temperature under nitrogen, was added 
DCC (1.06 g, 5.52 mmol) and DMAP (0.06 g, 0.49 mmol). After stirring at room 
temperature for 24 hours the mixture was filtered, diluted with EtOAc (50 mL), washed 
succesively with 5% KHSO4 (20 mL), saturated NaHC03 (20 mL) and saturated NaCl 
(20 mL) solutions, dried over Na2S0 4  and evaporated to dryness. A white powder was 
obtained. Yield: 2.01 g (82%); mp 122 °C-129 °C; lH NMR (250 MHz, CDCI3) d  2.8.
3.15 (m, 1H each, CH2Ph), 4.09 (m, 1H, CH fluorenyl), 4.26 (m, 1H, C H C H 2Ph),
4.32 (m, 2H, C 0 2CH2), 5.09 (m, 1H, NH), 5.41 (m, 2H, OCH2Ph), 7.08, (d, JPH= 
560 Hz, 1H, P-H), 7.25 (m, 16H, Ph + 11 H fluorenyl), 7.74 (d, 2H, fluorenyl); 31P 
NMR (101 MHz, DMSO) d  32.2, 32.9; MS (FAB (glycerol)) m/e 498.1 ((M + H)+). 
Analysis calc'd for C30H28N O 4P: C, 72.41; H, 5.68; N, 2.82; found: C, 72.32; H, 
5.79; N, 3.02.
l-[A-(9-fFluorenylmethoxycarbonyl)amino]-methanephosphinic acid, 
allyl ester (11).
To a solution of compound 8d (507 mg, 1.6 mmol) and allyl alcohol (0.15 mL, 
1.68 mmol) in dry CH2CI2 (4 mL) at room temperature under nitrogen, was added DCC 
(0.36 g, 1.76 mmol) and DMAP (19.5 mg, 0.16 mmol). After stirring at room 
temperature for 24 hours the mixture was filtered, diluted with EtOAc (10 mL) and 
washed succesively with 5% KHSO4 (8 mL), saturated NaHC03  (8 mL) and saturated 
NaCl solutions (8 mL), dried over Na2S04 and evaporated to dryness. A white powder 
was obtained. Yield: 0.4 g (66.7 %). 1H NMR (250 MHz, CDCI3) d  3.73 (m, 2H. 
C H 2 ), 4.2 (m, 1H, CH fluorenyl), 4.45 (d, 2H, C H 2OCO), 4.59 (m, 2H, 
O C H 2C H =C H 2 ), 5.34 (m, 2H, O C H 2CH=CH2), 5.93 (m, 2H, OCH2C H = C H 2 ),
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7.17 (d, Jph=561.2, 1H, P-H), 7.36 (m, 4H, 4 fluorenyl), 7.58 (d, 2H, fluorenyl),
7.77 (d, 2H, fluorenyl); 3lp NMR (101 MHz, DMSO) d 29.8.; MS (FAB (glycerol)) m/e
358.2 ((M + H)+); HRMS (FAB (MNBA)) m/e calc’d for C 19H 20NO4P ((M + H)+): 
358.1130; found: 358.1212.
l-[iV-(9-FIuorenyImethoxycarboiiyl)ainino]-l-methylethanephosphinic 
acid, allyl ester (12).
To a solution of compound 9d (500 mg, 1.45 mmol) and allyl alcohol (0.1 mL, 
1.52 mmol) in dry CH2CI2 (3.63 mL) at room temperature under nitrogen, was added 
DCC (0.33 g, 1.6 mmol) and DMAP (17.7 mg, 0.15 mmol). After stirring at room 
temperature for 24 hours the mixture was filtered, diluted w ith EtOAc (10 ml) and 
washed succesively with 5% KHSO4 (8 mL), saturated NaHC0 3  (8 mL) and saturated 
NaCl solutions, dried over Na2S04  (8 mL) and evaporated to dryness. A white powder 
was obtained. Yield 0.582 g (92.3 %).: m.p. 122-125 °C; *H NM R (250 MHz, CDCI3) 
d  1.48 (m, 6H, 2CH3), 4.21 (m, 1H, CH fluorenyl), 4.44 (d, 2H, CH2OCO), 4.56 (m, 
2H, OCH2C H = C H 2 ), 4.89 (brs, 1H, NH), 5.32 (m, 2H, O C H 2CH =CH 2 ), 5.92 
(m, 2H, OCH2C H =C H 2), 7.32 (d, JPH=569, 1H, P-H), 7.36 (m, 4H, 4 fluorenyl), 
7.58 (d, 2H, fluorenyl), 7.77 (d, 2H, fluorenyl); 31P NMR (101 MHz, DMSO) d  36.8. 
HRMS (FAB (MNBA)) m/e calc’d for C21H24NO4P ((M + H)+): 386.1443; found: 
386.1528.
l-[A^-(9-Fiuorenylmethoxycarbonyl)amino]-2-phenylethanephosphinic 
acid, allyl ester (13).
To a  solution of compound lOd (0.5 g, 1.23 mmol) and allyl alcohol (0 .1  mL, 
1.35 mmol) in dry CH2CI2 (10 mL) at room temperature under nitrogen, was added DCC 
(0.27 g, 1.29 mmol) and DMAP (0.02 g, 0.11 mmol). After stirring at room temperature 
for 24 hours the mixture was filtered, diluted with EtOAc (50 mL), washed succesively 
with 5% KHSO4 (20 mL), saturated N aH C 03 (20 mL) and saturated NaCl (20 mL) 
solutions, dried over Na2S04 and evaporated to dryness. A white powder was obtained.
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Yield: 0.39 g (68.8%); m.p. 122-129 °C; NMR (250 MHz, CDCI3) d  2.94, 3.23 (m. 
1H each, CH2Ph), 4.15 (m, 1H, CH fluorenyl), 4.29 (m, 1H, C H C H 2Ph), 4.38 (m, 
2H, C 0 2CH2), 4.58 (m, 2H, OCH2C H = C H 2 ), 4.98 (m, 1H, NH), 5.34 (brs, 1H, 
NH), 5.32 (m, 2H, OCH 2CH=CH2), 7.12 (d, JPH= 560 Hz, 1H, P-H), 7.39 (m, 13H, 
Ph + 8 H fluorenyl), 7.78 (d, 2H, fluorenyl); 3 lp  NMR (101 MHz, DMSO) d  31.9, 
32.4; MS (FAB (MNBA)) m/e 448.1 ((M + H)+); HRMS (FAB (MNBA)) m/e calc'd 
fo rC 26H26N04P ((M  + H)+): 448.1599; found: 448.1659.
2.2.8. Synthesis and Characterization of Model Phosphate and 
Phosphonamidate Dipeptides in Solution
Boc-Valy[P(S)(OfBu)0](S)Ala-OCH3 (15b).
It was prepared according to the general procedure (0.4 mmol scale) and purified 
by flash chromatography using EtOAc-hexane (1:10) as the eluent yielding a mixture of 
diastereomeric products. Yield: 49 mg (30%). Note: CH2C12 (adding 3.5 equiv. of 
Et3N at the start o f the reaction sequence) can be used as a solvent instead (reaction 
mixture slightly less concentrated, 0. 13 M) with almost identical results. lH NMR (300 
MHz, CDCI3) d 0.97 (m, 6H, CH (CH 3)2), 1.45 (s, 9H, (C H 3)3COCO), -1 .50 (m, 
3H, CH(CH3), obscurred by neighboring singlets), 1.55 (s, 9H, OtBu), 2.45, 2.49 
(2m, 1H, C H (C H 3)2), 3.77, 3.81 (2s, 3H, COOCH3), 3.99, 4.05 (2m, 1H, C H P), 
4.73 (d, 1H, NH), 5.06 (m, 1H, OCH(CH3)); 31P NMR (121.57 MHz, CDCI3) d 85.4, 
85.9. HRMS (FAB (MNBA)) m/e calc'd for C 17H35NO 6PS ((M + H)+): 412.1923; 
found: 412.1946.
Boc-Valy[P(S)(OfBu)NH]GIy-OCH2CH3 (16b)
It was prepared according to the general procedure except that Et3N (3.5 equiv.) 
was added to glycine ethyl ester hydrochloride before addition to the pyridine solution of 
the phosphonochloridite. Purification by flash chromatography using EtOAc-hexane 
(1:5) as the eluent provided two diastereomeric products. Total yield: 56 mg (40%). 
Note: CH2C12 (adding 3.5 equiv. o f Et3N at the start of the reaction sequence) can be
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used as a solvent instead (reaction mixture slightly less concentrated, 0. 13 M) with 
almost identical results. Diast. 1: NMR (250 M Hz, CDC13) d 1.03 (dd, 6H,
C H (C H 3)2), 1.27 (t, 3H, COOCH2C H 3), 1.42 (s, 9H, CO O C (C H 3)3), 1.56 (s, 9H, 
OC(CH 3)3), 2.16 (m, 1H, CH (CH 3)2), 3.27 (m, 1H, N H (C H 2)), 3.63 (m, IH, CH), 
3.90 (m, 2H, N H (C H 2)), 4.18 (q, 2H, C O O C H 2CH3), 4.88 (d, 1H, BocNH); 3ip  
NMR (101 M Hz, CDC13) d 71.98. HRMS (FAB (M NBA)) m /e  calc’d for 
C 17H36N 20 5PS ((M + H)+): 411.2082 ; found: 411.2079. Diast 2: *H NMR (250 
MHz, CDC13) d 0.97 (dd, 6H, CH(CH3)2), 1.25 (t, 3H, COOCH2C H 3), 1.46 (s, 9H, 
C O O C (C H 3)3), 1.52 (s, 9H, OC(CH3)3), 2.41 (m, 1H, C H (C H 3)2), 3.35 (m, 1H, 
NH(CH2)), 3.84 (m, 3H, CH, NH(CH2)), 4.20 (q, 2H, C O O C H 2CH 3), 4.83 (d, 1H, 
BocNH); 31P NMR (101 MHz, CDC13) d 71.01. HRMS (FAB (MNBA)) tn/e calc'd 
for C i7H36N20 5PS ((M + H)+): 411.2082; found: 411.2096. 
F m o c -A ib y [P (0 )(O B n )]G ly -O C H 2 C H 3 (19)
It was prepared according to the general procedure (0.23 mmol scale) and purified by 
flash chromatography using EtOAc-hexane (3:1) or CH2Cl2-EtOAc (1:1) as the eluent 
yielding a white solid as a product. Yield: 74 mg (60%). Note: CH2C12 (adding 3.5 
equiv. of Et3N at the start of the reaction sequence) can be used as a solvent instead. •H 
NMR (250 MHz, CDCl3) d  1.26 (t, 3H, COOCH2C H 3), 1.57 (m, 6H, 2C H 3), 3.83 
(m, 3H, C H 2C O O C H 2CH 3 + N H), 4.17 (m, 3H, C O O C H 2C H 3 + C H C H 2OCO). 
5.06 (m, 3H, O C H 2Ph + NH), 7.33 (m, 9H, CH2Ph +  4 fluorenyl), 7.55 (d, 2H, 
fluorenyl), 7.77 (d, 2H, fluorenyl); 31P NMR (101 MHz, CDCI3) d  28.2. MS (FAB 
(M NBA)) m /e  537.1 ((M + H)+); HRMS (FAB (M NBA)) m /e  calc'd for 
C29H33N20 6P ((M + H)+): 537.2076; found: 537.2142. 
F m o c-A ib y [P (S )(O B n )]G ly -O C H 2C H 3 (20)
It was prepared according to the general procedure (0.35 mmol scale) and 
purified by flash chromatography using EtOAc-hexane (2:10) as the eluent yielding a 
yellow oil as a product. Yield: 50 mg (40%). Note: CH2C12 (adding 3.5 equiv. of
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Et3N at the start o f the reaction sequence) can be used as a solvent instead. *H NMR (250 
MHz, CDCI3) d  1.26 (t, 3H, COOCH2C H 3), 1.62 (m, 6H, 2 C H 3), 3.91 (m, 2H, 
C H 2C O O C H 2C H 3), 4.19 (m, 3H, C O O C H 2C H 3 + C H C H 2OCO), 4.25 (brs, 1H, 
NH), 4.35 (d, 2H, C H CH 2OCO), 5.06 (m, 2H, O C H 2Ph), 5.23 (brd, 1H, NH), 7.34 
(m, 9H, CH2P h  +  4 fluorenyl), 7.58 (d, 2H, fluorenyl), 7.76 (d, 2H, fluorenyl); 31p 
NMR (101 MHz, CDCI3) d  92.7. MS (FAB (MNBA)) m/e 553.3 ((M + H)+). Analysis 
calc’d for C29H 33N 2O 5PS: C, 63.02; H, 6.02; N, 5.07; found: C, 62.91; H, 5.87; N, 
5.30.
F m o c -P h ey [P (0 )(O B n)]G Iy -O C H 2 C H 3 (21)
It was prepared according to the general procedure (0.2 mmol scale) using 2.0 
eq. o f Ph3PCl2 instead of 1.5 eq. and purified by flash chromatography using CH2CI2- 
EtOAc (1:1) as the eluent yielding a white solid as a product. Yield: 23 mg (20%). 
CH2CI2 (adding 4.0 equiv. of Et3N at the start o f the reaction sequence) has been used as 
a so lven t. !H NMR (250 MHz, CDCI3) d  1.23 (m, 3H, COOCH2C H 3), 2.93 (m, 1H. 
C H 2C O O CH 2C H 3), 3.27 (m, 1H, C H 2C O O C H 2C H 3), 3.7 (m, 2H, C H 2Ph), 4.18 
(m, 5H, CO OCH2C H 3 + CH CH 2OCO + C H C H 2OCO + C H C H 2Ph), 5.4 (m, 3H, 
O C H 2Ph + NH), 7.4 (m, 9H, CH2P h  + 4 fluorenyl), 7.55 (d, 2H, fluorenyl), 7.74 
(d, 2H, fluorenyl): 31P NMR (101 MHz, CDCI3) d  29.3, 28.03.; MS FAB (MNBA) 
m/e 599.7 ((M + H)+); HRMS (FAB (MNBA)) m/e calc'd for C34H35N2O6P ((M + 
H)+): 599.2233; found: 599.2343.
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CHAPTER 3. SOLID PHASE SYNTHESIS OF PHOSPHONOPEPTIDES
3.1. Synthetic Approach or Strategy
The envisioned strategy for incorporation o f phosphonate and phosphonamide 
substitutions into a peptide chain is described (Scheme 3.1). Applying solid-phase 
techniques, an activated phosphonous amino acid is added to an existing resin-bound 
oligomer containing an amino or alcoholic nucleophile. After coupling, reaction with an 
oxygen or sulfur electrophile provides the desired phosphonate or phosphonamide 
linkage. Deprotection followed by additional coupling cycles if necessary with 
activated amino acids produces the desired phosphonate/phosphonam ide peptide 
analog.
3.2. General Aspects of Phosphono-Peptide Solid-Phase Synthesis
A solid-phase synthesis scheme with ^/“ -protection provided by the Fmoc group 
has been chosen for five reasons: a) solid-phase synthesis57 allows the use o f excess 
reagents to drive coupling reactions to completion, therefore improving yields; b) 
combinatorial chemistry58*59 for developing arrays or libraries are the future for 
peptide- and non-peptide-related drug discovery, and is almost exclusively carried out 
on the solid-phase; c) The sensitive nature of the phosphonamide linkages to multiple 
treatments with medium strength acids (trifluoroacetic acid) requires the use of Fmoc- 
based strategies; d) the mild conditions needed for removal of the Fmoc-group will 
allow the development o f orthogonal methods60*6-  that will be useful in future studies 
o f phosphono-peptides having side-chain functionality that need protection or 
modification, and/or development of techniques for solid-phase synthesis o f cyclic 
derivatives60-63*64 and e) the simple spectrophotometrically assay of the deprotection 
products to determine the coupling and loading yields o f the peptide segments.65
53
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General methods for Fmoc-based solid-phase synthesis are as described by 
Barany and Fields.57 As our targets contain no side-chain functionalities, this need not 
be considered at the present time, though r-butyl- or allyl-based protection of side-chain 
groups would be compatible with this strategy. In the case where phosphonate ester 
peptides are synthesized, attachment o f the first amino acid to the support is provided 
by co m m erc ia lly -av a ilab le  tr if lu o ro ace tic  a c id  (T F A )-lab ile  handles: 
4-hydroxymethylphenoxyacetic acid57 (PAC) for peptide acids and 5-(4-aminomethyI- 
3,5-dimethoxyphenoxy)valeric or butanoic acid57 (PAL) for peptide amides. In the case 
where phosphonamide peptides are synthesized, attachment o f the first amino acid to 
the support is provided by base labile or photolabile handles: glycoamidic ester663 
linker for peptide acids and ortho-nitrobenzyl photolabile linker for peptide amides666 
(Figure 3.1).
HOCH2 o c h 2c o 2h
PAC
CH °
Fmoc-NHCH2 0 (C H 2)nC 0 2H
CH30 PAL
011
B r-C H 2-C -O H
glycoamidic ester linker
0 2N
H  / - o ( c h 2)3c o 2h
Fmoc-NH M
OCH3
o-Nitrobenzyl photolabile linker
Figure 3.1. Handles for Fmoc-based Solid-Phase Peptide Synthesis
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The resins o f choice are polyethyleneglycol-polystyrene (PEG-PS) and Tentagel as 
they swell well in a wide range of solvents and have physical properties that appear to 
improve peptide synthesis.67' 71 This compatibility with multiple solvents is important 
for the optim ization o f both phosphorus amino acid coupling and the 
phosphonite/phosphonamidite oxidation/sulfurization protocols. Normal amino acid 
coupling cycles use 0 -(7 -A zab en zo triazo l-l-y l)-l,l,3 ,3 -te tram e th y lu ro n iu m  
hexafluorophosphate72 (HATU) in the presence o f diisopropylethylamine (DIEA).
Deprotection is performed with 20% piperidine in DMF because of potential 
side-reactions with the phosphonate protecting group when using stronger bases. All 
solid-phase syntheses are carried out by hand using polypropylene syringes fitted with 
porous frits (see ref 64 for an example).
Clean and fast cleavage of the phosphonoester protecting group is critical to 
obtain good yields of the free phosphonopeptides. Benzyl protection has been chosen 
based on the success o f a similar strategy for the preparation o f phosphotyrosine 
peptides using Fmoc-protected amino acids, dibenzylester protection o f the phosphate 
group, and final cleavage with TFA-based cocktails.73 If concentrated TFA solutions 
cause degradation of the peptides (a serious concern with phosphonamides,7’74 an 
alternative strategy with an orthogonal mechanism of cleavage like Pd(0) for an allyl 
ester60-75 and a photolabile linker or a base labile linker is employed. Conditions for 
allyl cleavage are particularly mild, using only Pd(0) and a mild nucleophile like N- 
methylmorpholine.75 Final deprotection with photolysis is performed. It is important to 
establish that the final deprotection conditions will actually provide the free 
phosphonate or phosphonamide peptide.
For the synthesis o f phosphonate-containing peptides, enantiomerically pure, 
protected a-hydroxy acids were required. The protected a-amino-alkyl-//-phosphinate 
esters 9-12 were prepared as described in chapter 2.
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3 i .  Results and  Discussion
3.3.1. Synthesis o f a-O -Fm oc-Protected H ydroxy Acid
The protected a-O -F m oc-pro tected  hydroxy acid 24 w as prepared by 
esterification o f the enantiomerically pure L-3-phenyllactic acid, protection of the 
hydroxyl functionality as fluorenylmethyloxycarbonate and hydrolysis o f the latter 
compound -  a scheme used successfully by Campbell in the solid-phase synthesis of 
phosphonate peptides32' 33 (Scheme 2.2).
H O . 1  CH3OH, H2SQ 4 - h o J L .
* ^ O H  in CH2CI2, reflux ° Me
Bn 2 2 Bn
22
Fmoc-Cl 
in pyridine
_ dioxane _
V 1 N HCI V
Y ^ o h  " r "0cOy A o m .
Bn Bn
FmocO
24  2 3
Scheme 3.2. Synthesis of Fm oc-protected a-H ydroxy A cid 24
3.3.2. Solid-Phase Synthesis of Phosphonopeptide Inhibitors
3.3.2.I. SPPS of Carboxypeptidase Inh ib ito rs
(i) Z-A ib^[(POOBn)NH]-Phe-OH (25)
(ii) Z-Aib yf[(POO")NH] -Phe-OH (26)
(iii) Z-GIy v^(POO")NH]-Phe-OH (27)
(iv) H2N-Aibv4(POOBn)NH]-Phe-NH2 (28)
The phosphonamide peptide analogs Z-Aibyi[(POOBn)NH]-Phe-OH (25), Z- 
Aibv4(POO-)NH]-Phe-OH (26) and Z-Glyy^(POO-)NH]-Phe-OH (27) were prepared 
using an Fmoc/Bn and an Fmoc/allyl strategy, respectively. The synthesis started from 
commercially available H2N-PEG-PS resin. In this case, final cleavage must be neutral 
or basic, so we have chosen to use the glycoamidic ester linker developed by Calas and
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coworkers,66a which is cleaved by base hydrolysis. Bromoacetic acid was coupled to 
NH2-PEG-PS with DCC and the Fmoc-Phe-OH coupled to the bromoacetate support in 
DIEA/DMF (loading 0.18 mmol/g; 80%). After removal o f the Fmoc group, the resin 
was dried in vacuo and the pre-activated protected amino acid was added under argon. 
After washing, r-BuOOH was added to produce the P(V) resin-bound peptide. The 
coupling yield is about 50%-55% effective (Fmoc analysis). After removal o f the Fmoc 
group, the N-terminal Z-group was added by N-(Benzyloxycarbonyloxy)succinimide 
(Z-OSu) in DIEA/DMF. The allyl group was cleaved using Pd(PPh3)4 and morpholine 
in DMSO/THF/HC1. Cleavage with NaOH in isopropanol-H20  produced the desired 
phosphonopeptides. The crude phosphonopeptides 25, 26 and 27 were characterized by 
3IP NMR. (Scheme 3.3) Because of the instability of these phosphonamidate peptides, 
attempts to isolate and purify them by HPLC were unsuccesful. The stability o f these 
types of compounds was tested by Bartlett and M oroder at different pHs and 
temperatures.7’74 At T=12 °C, pH=6.0 the halftime decomposition is 70 h, and at 
pH=7.0 it is 2 weeks. At room temperature and pH=8 the decomposiuon is 10% after 44 
h but at T= 12 °C the compounds show no decomposition after 8 days.74 Moreover, at 
pH 8.5, stock solutions appear to be stable indefinitely at 5 °C.7
An attempt to synthesize phosphonopeptide 28 was accomplished in order to 
analyze it directly by MALDI-TOF M S.77 The resin o f choice was the commercially 
available NH2-Tentagel. After coupling the ortho-nitrobenzyl photolabile linker to the 
support using 1-hydroxybenzotriazole (HOBt) / 1 ,3-diisopropyl carbodiimide (DIC) and 
DDEA (loading 0.2 mmol/g; 70%), Fmoc-Phe-OH was attached with HATU/DIEA 
(loading 0.2 mmol/g; 100%). After removal o f  the Fmoc group, the resin was dried in 
vacuo and the preactivated protected amino acid was added. After washing, rBuOOH 
was added to produce the phosphonopeptide bound to the resin. The coupling yield is 
about 40% effective (Fmoc analysis). After removal of the Fmoc group, a portion of 
this resin was taken and directly analyzed by M ALDI-TOF mass spectrometry.
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Attempts to characterize the phosphonopetide 28 by this methodology were 
unsuccesful.
3.3.2.2. SPPS of Thermolysin Inhibitors:
(i) Z-Phe- v^(P00~)0]Phe-Ala-NH2 (29)
The phosphonate peptide analog, Z-Phe- t/f[(P00“)0]Phe-A la-N H 2 (29) was 
prepared using an Fm oc/Bn strategy. The Fm oc-Ala-OH was attached to a 
tris(alkoxy)benzylamide support (-PAL-PEG-PS) using HATU/DIEA (loading 0.15 
mmol/g, 100% of capacity). After removal of the Fmoc group, the a-O-Fmoc-protected 
hydroxy acid 24 was charged with HATU/DIEA (loading 0.124 mmol/g; 83%). After 
removal of the Fmoc group, the resin was dried in vacuo and the preactivated protected 
amino acid was added. After washing, rBuOOH was added to produce the P(V) resin 
bound peptide. The coupling yield is about 70% effective (Fmoc analysis). The Fmoc 
group was then cleaved, and the N-terminal Z-group was added by Z-OSu in DMF in 
the presence of DDEA. Cleavage with TFA produced the free phosphonopeptide. The 
crude peptide product was purified by reverse-phase HPLC and analyzed by FAB mass 
spectrometry (Scheme 3.4).
In general the overall yields obtained by Fmoc analysis in the preparation of 
phosphonopeptides by solid-phase were moderate to good (40-60%). In comparison, 
Campbell et al.32-33 obtained overall yields greater than 90% in the case of phosphonate 
esters. However, their coupling reaction times are longer when using sterically hindered 
alcohols. Reaction times using our methodology are shorter (30 min to 1 h). In addition 
our method is applicable to solid-phase synthesis o f phosphonamides and phosphonate 
peptides. In summary, the phosphonoamidate peptides 25-27 could not be isolated or 
purified due to instability factors, but we could isolate purify and characterize the 
phosphonate peptide 29. Our attempts to characterize the phosphonopeptide 28 bound 
to the resin directly by MALDI-TOF MS were unsuccesful.
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Scheme 3.3. Solid-Phase Synthesis of Phosphonopeptides 25*27
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3.4. Experimental Material
3.4.1. Technical Information
Unless otherwise noted, material were obtained from commercial suppliers and 
used without further purification. Triethylamine was dried and refluxed over CaH2 and 
then distilled directly onto dry m olecular sieves (3 A). Anhydrous CH2CI2 was 
purchased from Aldrich. DMF and 20% piperidine solution in DMF were obtained from 
Perseptive Biosystems GmbH. Fmoc amino acids were obtained from Advanced 
Chemtech. -PAL-PEG-PS (0.15 mm ol/g) and PEG-PS (0.2 mmol/g) resins were 
purchased from Millipore and NovaSyn TG resin (0.29 mmol/g) was obtained from 
Novabiochem. Ultraviolet -visible spectra were obtained on a AVTV 14DS UV-VIS-IR 
spectrophotometer. Analytical HPLC was performed on Zorbax 300 SB.C18 (5 Jim 
particle size; 0.46 x 25 cm) and preparative HPLC were performed on Waters PrepLC 
25 mm (15 pm  particle size; 2.5 x 10 cm) Module on a Waters Millipore two pump 
system 600E equipped with a variable wavelength detector 486 and an autoinjector 
717. MALDI experiments were performed on a Perseptive Voyager MALDI mass 
spectrometer.
3.4..2. General Experimental Conditions for the Solid Phase Synthesis of
Peptidylphosphonates
Standard peptide-synthesis couplings using N-Fmoc amino acid were performed 
with any of the commonly used coupling reagents. After the desired sequence had been 
synthesized, the Fmoc group was removed using 20% piperidine solution in DMF (2 
mL) for 30 min, the resin (200 mg) was washed with DMF ( 4 x 2  mL) and CH2CI2 (4 x 
2 mL) and then dried under high vacuum for at least an hour.
At room temperature, a solution of Ph3PCl2 (95% purity, Aldrich, 15 eq) in 
CH2CI2 was added dropwise to a solution of the protected phosphinate amino acid ester 
9-12 (10 eq) and NEt3 (15 eq) in CH2CI2 with stirring. Concentrations are chosen such 
that the reaction mixture contains 0.1 M of the protected phosphinate amino acid ester. 
After 20 min this solution was added to the resin under argon and left for one hour.
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After washing with anhydrous CH2CI2 ( 2 x 2  mL), f-BuOOH (50 eq) was added and the 
reaction mixture left for an hour. The P(V) resin-bound peptide was washed with DMF 
( 4 x 2  mL) and CH2CI2 ( 2 x 2  mL) and dried under high vacuum for at least an hour. 
Fmoc UV analysis was performed on 4-8 mg o f resin.65 If the coupling yield was low, 
a second coupling was carried out under the same conditions. A fter removal o f the 
Fmoc group with 20% piperidine solution in DMF (2 mL) for 30 min, Z-OSu (5 eq) 
and DIEA (15 eq) in DMF (0.1 M) were added. The resin was washed with DMF ( 4 x 2  
mL) and CH2CI2 ( 2 x 2  mL).
3.4.3. SPPS of Carboxypeptidase Inhibitors
HC1 x NH2-PEG-PS resin (1 g, 0.2 mmol) was washed with CH 2CI2 ( 4 x 5  mL), 
30% TFA solution in CH2CI2 ( 4 x 5  mL), 10% DEEA solution in CH2CI2 ( 4 x 5  mL), 
CH2CI2 ( 4 x 5  mL) and DMF ( 4 x 5  mL). Ninhydrin test was positive.
Bromoacetic acid ( 166.74 mg, 1.2 mmol) was dissolved in C H 2CI2 (3mL). The 
mixture was cooled at 0 °C; DCC was added (123.8 mg, 0.6 mmol). After 20 min of 
stirring, the dicyclohexylurea (DCU) formed was removed by filtration. The 
bromoacetic anhydride (156 mg, 0.6 mmol) mixture was added to the resin and shaken 
for 1 hour. After filtration of the solvent, the resin was washed with CH2CI2 ( 4 x 5  mL). 
Ninhydrin test is practiced on a few beads of resin; if positive, a second coupling was 
carried out under the same conditions.
Fmoc-Phe-OH (387.4 mg, 1 mmol) and DIEA (0.16 mL, 0.9 mmol) were mixed 
in DMF (10 mL) and the mixture added to the resin. After 30 h the loading was 0.18 
mmol/g (80%) as determined by Fmoc UV analysis. The resin was washed with DMF 
(4 x 10 mL) and CH2Cl2-(4 x 10 mL). Ninhydrin test was performed. Resin was stored 
at 5 °C and kept for future use.
Portions o f 200 mg (0.04 mmol) of the above resin were taken for SPPS. 
Removal of the Fmoc group was performed with 20% piperidine solution in DMF (2
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mL) for 30 min. The resin was washed with DMF ( 4 x 2  mL), CH2CI2 ( 4 x 2  mL) and 
dried in vacuo for at least 1 h.
Cleavage o f the phosphonopeptide from the glycoamidic resin was carried out 
with 3 eq of 1M NaOH in isopropanol-H2 0  70:30 for 24 h. The resin was filtered, 
washed extensively with MeOH ( 5 x 2  mL) and placed under high vacuum to remove 
the MeOH.
(i) Z-Aib v^(POOBn)NH]-Phe-OH (25).
Coupling o f the protected phophinate amino acid ester 9 (156.6 mg, 0.36 mmol) 
was performed according to the general procedure (see section 3.5.2). The coupling 
yield was 50% (0.09 mmol/g) (Fmoc analysis). After cleaving the phosphonopeptide 
from the resin, the crude product was obtained with another phosphorus compound 
impurity (31P = 25.2 ppm). 3IP NMR (250 MHz, D20 )  8 31.6.
(ii) Z-Aib y/[(POO')NH]-Phe-OH (26).
Coupling o f the protected phophinate amino acid ester 12 (138.6 mg, 0.36 
mmol) was performed according to the general procedure (see section 3.4.2) giving a 
coupling yield o f 50% (0.09 mmol/g) (Fmoc analysis). The allyl group was deprotected 
using 50 eq of N-methylmorpholine (0.08 mL, 0.9 mmol) in the presence o f Pd(PPh3)4 
(3 mg, 0.0026 mmol) in 2:2:1 DMSO/THF/O.5 M HC1 (1.4 mL in total) at room 
temperature for 18 h under argon.73 The resin was washed with DMF ( 4 x 2  mL) and 
CH2CI2 ( 4 x 2  mL). After cleaving the phosphonopeptide from the resin, the crude 
product was obtained with another phosphorus compound impurity (31P = 24.6 ppm). 
31P NMR (250 MHz, D20 )  8 21.5.
(iii) Z-Glyv^(POO-)NH]-Phe-OH (27).
Coupling o f the protected phophinate amino acid ester 11 (128.5 mg, 0.36 
mmol) was performed according to the general procedure (see section 3.4.2). The 
coupling yield was 55% (0.099 mmol/g) (Fmoc analysis). The allyl group was 
deprotected as described above for phosphonopeptide 26. A fter cleaving the
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phosphonopeptide from the resin, the crude product was obtained with two other 
phosphorus compound impurities (31P = 15.7 ppm and 19.3 ppm). 31P NMR (250 MHz, 
D20 )  5 18.0.
(iv) H2N-Aiby[(POOBn)NH]-Phe-NH2 (28).
Attempt to synthesize phosphonopeptide 28 w as accomplished in order to 
analyze it directly by MALDI-TOF MS.77 The resin o f choice was the commercially 
available NH2-Tentagel (200 mg, 0.058 mmol; 0.29 mmol/g). After washing the resin 
with DMF ( 4 x 2  mL) and CH2C12.(4 x 2 mL), 5 eq o f the ortbo-nitrobenzyl photolabile 
linker (150.7 mg, 0.29 mmol) was coupled to the support using 5 eq of HOBt (39.2 mg, 
0.29 mmol), 5 eq of DIC (0.045 mL, 0.29 mmol), 5 eq o f DIEA (0.05 mL, 0.29 mmol 
and a reaction time o f 2 h (loading 0.165 mmol/g; 57%). A second coupling was 
performed with a reaction time o f 13 h (loading 0.2 mmol/g; 70%). Fmoc-Phe-OH 
(77.48 mg, 0.2 mmol) was attached with HATU (76.0 mg, 0.2 mmol) and DIEA (0.07 
mL, 0.4 mmol) (loading 0.2 mmol/g; 100%). Coupling o f  the protected phosphinate 
amino acid ester 9 (174 mg, 0.4 mmol) was perform ed according to the general 
procedure (see section 3.4.2). The coupling yield is about 40% (0.08 mmol/g) (Fmoc 
analysis). After removal o f  the Fmoc group, a portion o f this resin was taken and 
directly analyzed by MALDI-TOF mass spectrometry. Attempts to characterize the 
phosphonopeptide 28 by this methodology were unsuccesful.
3.4.4. SPPS of Thermolysin Inhibitors
(i) Z-Phe i/4!(P00")0]-Phe-AIa-NH2 (29).
•PAL-PEG-PS resin (300 mg, 0.045 mmol; 0.15 mmol/g) was washed with 
CH2C12 ( 4 x 3  mL) and DMF ( 4 x 3  mL). Ninhydrin test was positive. Fmoc-Ala-OH (
77.0 mg, 0.225 mmol) was attached with HATU (85.6 mg, 0.225 mmol) and DIEA 
(0.08 mL, 0.450 mmol) in DM F (2.25 mL) (loading 0.15 mmol/g; 100%). After 
removal o f the Fmoc group, a solution containing the a-O -Fm oc-protected hydroxy 
acid 24 (87.3 mg, 0.225 mmol) and HATU/DIEA in DM F using the same conditions
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as the Fmoc-Ala-OH coupling (loading 0.124 mmol/g; 83%). Coupling of the protected 
phophinate amino acid ester 10 (223.9 mg, 0.450 mmol) was performed according to 
the general procedure (see section 3.4.2). The coupling yield was about 70% (loading 
0.087 mmol/g) by Fmoc analysis. The Fmoc group was cleaved, and the N-terminal Z- 
group was added by Z-OSu/DIEA in DMF. Clevage was performed with a mixture of 
88% TFA, 5% phenol, 5% H2O, 2% triisopropylsilane and a reaction time of 2 h. The 
resin was washed with CH2CI2 ( 4 x 3  mL) and the solvent rotavapped. Water (5 mL) 
was then added and the aqueous solution washed with ether ( 3 x 5  mL). The aqueous 
layer was centrivaped to produce the crude phosponopeptide 29 which was purified by 
HPLC. The following conditions were used for analytical HPLC: linear gradient over 
45 min of 90% solution A (0.1 % TFA in H2O) and 10% solution B (0.1 % TFA in 
CH3CN:H20 4:1), flow rate 1 mL/min over 45 min on a Zorbax column; tR= 20 min. 
MS (FAB (MNBA)) m/e 552.5 ((M - H)+).
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Appendix 1. lH NMR spectrum of O-Benzyl-0-isopropyl-P-phenyl-phosphonate ( lb )
at 250 MHz in CDCI3 .
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Appendix 2. 31P NMR spectrum of O-Benzyl-O-isopropyl-P-phenyl-phosphonate (lb )
at 101 MHz in CDC13.
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Appendix 3. lH NMR spectrum of A^A-Diethyl-O-isopropyl-P-phenyl- 
phosphonamidate (lc) at 250 MHz in CDCI3.
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Appendix 4. 31P NMR spectrum o f N.yV-Diethyl-CMsopropyl-P-phenyl-
phosphonamidate ( lc )  at 101 MHz in CDCI3 .
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Appendix 5. *H NMR spectrum of O-Isopropyl-O-methyl-P-phenyl-phosphonothioate
(Id) at 250 MHz in CDC13.
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Appendix 6. 31P NMR spectrum of O-Isopropyl-O-methyl-P-phenyl-phosphonothioate
(Id) at 101 MHz in CDC13.
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Appendix 7. NMR spectrum of <9-Ethyl-(7-isopropyl-P-phenyl-phosphonothioate
(le) at 250 MHz in CDC13.
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Appendix 8. 31P NMR spectrum of O-Ethyl-0-isopropyl-P-phenyI-phosphonothioate
(le) at 101MHz in CDC13.
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Appendix 9. NMR spectrum of 0,0-Diisopropyl-P-phenyl-phosphonothioate (If) at
250 MHz in CDC13.
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Appendix 10. 31P NMR spectrum of O,O-Diisopropyl-f-phenyl-phosphonothioate (If)
at 101 MHz in CDCI3.
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Appendix 11. *H NMR spectrum of O-Benzyl-0-isopropyl-P-phenyl-phosphonothioate
(lg) at 250 MHz in CDCI3.
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Appendix 12. 31P NMR spectrum of 0-Benzyl-(9-isopropyl-P-phenyl-phosphonothioate
(lg) at 101 MHz in CDC13 .
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
8 5
8. 0 7 .0 5 .06 . 0 4 .0 3 .0 2. 0 1 . 0 0 . 0
PPM
Appendix 13. *H NMR spectrum of 0-f-Butyl-O-isopropyl-P-phenyl-phosphonothioate
(lh ) at 250 MHz in CDC13.
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Appendix 14. 3!p  NMR spectrum of O-f-Butyl-0-isopropyl-P-phenyl- 
phosphonothioate (lh) at 101 MHz in CDCI3.
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Appendix 15. !H N M R  spectrum of//-Benzyl-O-isopropyl-P-phenyl- 
phosphonamidothioate (li) at 250 MHz in CDCI3.
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Appendix 16. 3IP N M R  spectrum of Af-Benzyl-O-isopropyl-P-pheny 1- 
phosphonamidothioate (li) at 101 MHz in CDCI3.
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Appendix 17. NMR spectrum of MiV-Diethyl-O-isopropyl-P-phenyl- 
phosphonamidothioate (lj) at 250 M Hz in CDCI3.
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Appendix 18. 3IP NMR spectrum of N,N-Diethvl-0-isopropyl-P-phenyI- 
phosphonamidothioate ( lj)  at 101 MHz in CDCI3.
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Appendix 19. !H NMR spectrum of N-t-Butyl-O-isopropyl-P-phenyl- 
phosphonamidothioate (lk ) at 250 MHz in CDCI3.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
Appendix 20. 31P NMR spectrum of iV-r-Butyl-O-isopropyl-P-phenyl- 
phosphonamidothioate (lk )  at 101 MHz in CDCI3.
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Appendix 21. NMR spectnxm of O-Isopropyl-P-phenyl-5-phenyl- 
phosphonodithioate (11) at 250 MHz in CDCI3.
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Appendix 22. 31P NMR spectrum of O-Isopropyl-P-phenyl-S-phenyl- 
phosphonodithioate (II) at 101 MHz in CDCI3.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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Appendix 23. lH NMR spectrum of A^-r-butyl-O-r-butyl-P-methylphosphonothioate
(lm ) at 250 MHz in CDCI3.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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Appendix 24. 31P NMR spectrum of A^-f-butyl-O-r-butyl-P-methylphosphonothioate
(lm ) at 101 MHz in CDC13.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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Appendix 25. NMR spectrum of 5-r-Butyl-O-methyl-P-methyl-phosphonothioace
(In) at 250 MHz in CDCI3.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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Appendix 26. 3lP NMR spectrum of 5-r-Butyl-<9-methyl-P-methyl-phosphonothioate
(In) at 101 MHz in CDCI3.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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Appendix 27. lH NMR spectrum of AM3enzyl-O-isopropyI-AL(0-isopropyl-/,-phenyl- 
thiophosphonyl)-.P-phenyl-phosphonamidothioate (5) at 250 MHz in CDCI3.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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Appendix 28. 31P NMR spectrum of Af-BenzyI-<9-isopropyl-./V-(CMsopropyl-P-phenyl- 
thiophosphonyl)-P-phenyl-phosphonamidothioate (5) at 101 MHz in CDCI3.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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Appendix 29. *H NMR spectrum of Boc-Vali/^P(S)(OrBu)0 ](S)Ala-OCH3 (15b) at
300 MHz in CDC13.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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Appendix 30. 31P NMR spectrum of Boc-Vali//[P(S)(OrBu)0 ](5r)Ala-OCH3 (15b) at
122 MHz in CDC13.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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Appendix 31. lH NMR spectrum of Boc-Vali//[P(S)(OfBu)NH]Gly-OCH2CH3 (16b)
Diast. I. at 250 MHz in CDCI3 .
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Appendix 32. 31P NMR spectrum of Boc-Vali//[P(S)(OtBu)NH]Gly-OCH2 CH3 (16b)
Diast. 1. at 101 MHz in CDCI3 .
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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Appendix 33. *H NMR spectrum of Boc-Valt/f[P(S)(OrBu)NH]Gly-OCH2 CH3 (16b)
Diast. 2. at 250 MHz in CDCI3 .
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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Appendix 34. 3IP NMR spectrum of Boc-Valy/(P(S)(OrBu)NH]Gly-OCH2CH3 (16b)
Diast. 2. at 101 MHz in CDCI3 .
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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Appendix 35. !H NMR spectrum of Fmoc-Aiby/[P(0 )(OBn)]Gly-OCH2CH3 (19) at
250 MHz in CDC13.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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Appendix 36. 31P NMR spectrum of Finoc-Aiby/[P(0 )(OBn)]Gly-OCH2CH3 (19) at
101 MHz in CDC13.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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Appendix 37. !H NMR spectrum of Fmoc-Aibi//[P(S)(OBn)]Gly-OCH2CH3 (20) at
250 MHz in CDC13.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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Appendix 38. 31P NMR spectrum of Fmoc-Aibi//[P(S)(OBn)]Gly-OCH2 CH3  (20)
101 MHz in CDC13.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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Appendix 39. lH NMR spectrum of Fmoc-Phei//[P(0 )(OBn)]Gly-OCH2CH3 (21) at
250 M Hz in CDCI3.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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Appendix 40. 31P NMR spectrum of Fmoc-Phey/[P(0)(OBn)]Gly-OCH2CH3 (21) i
101 MHz in CDCI3.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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